WO2015024119A1 - Plantes produisant des graines qui éliminent la chlorophylle pendant la maturation dans des conditions de stress - Google Patents

Plantes produisant des graines qui éliminent la chlorophylle pendant la maturation dans des conditions de stress Download PDF

Info

Publication number
WO2015024119A1
WO2015024119A1 PCT/CA2014/050793 CA2014050793W WO2015024119A1 WO 2015024119 A1 WO2015024119 A1 WO 2015024119A1 CA 2014050793 W CA2014050793 W CA 2014050793W WO 2015024119 A1 WO2015024119 A1 WO 2015024119A1
Authority
WO
WIPO (PCT)
Prior art keywords
plant
seq
sequence
abi3
expression
Prior art date
Application number
PCT/CA2014/050793
Other languages
English (en)
Inventor
Marcus A. SAMUEL
Frédéric DELMAS
Original Assignee
8411824 Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 8411824 Canada Inc filed Critical 8411824 Canada Inc
Priority to CA2921071A priority Critical patent/CA2921071A1/fr
Publication of WO2015024119A1 publication Critical patent/WO2015024119A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • the present invention relates to plants that produce seeds with the phenotype of removing chlorophyll during maturation under stress conditions.
  • the invention relates to modulation of the transcription factor ABB and its targets SGR1 or SGR2 in plants or plant seeds to maintain the ability of the plant seed to remove chlorophyll, even under a stress such as cold temperatures, drought conditions, osmotic stress and other environmental stresses.
  • angiosperms impinges on their ability to desiccate and protect their embryos in a dormant state until favorable conditions are perceived.
  • this desiccation process during seed maturation is intricately coupled to loss of chlorophyll from photosynthetically active embryos.
  • the embryo maturation phase as the embryos begin to lose their chlorophyll, they concomitantly initiate the process of acquisition of desiccation tolerance and dormancy, thereby producing mature, brown (de-greened) and dormant seeds.
  • Chlorophyll is essential for light capture and is the starting point that provides the energy for photosynthesis and thus plant growth. Obviously, for this reason, retention of the green chlorophyll pigment is considered a desirable crop trait. However, the presence of chlorophyll in mature seeds can be an undesirable trait that can affect seed maturation, seed oil quality and meal quality. Occurrence of mature green seeds in oil crops such as canola and soybean due to unfavorable weather conditions during seed maturity is known to cause severe losses in revenue.
  • An object of the invention is to provide a means to induce in a plant the ability to produce seeds that remove chlorophyll under stress conditions.
  • the present invention relates to a method of inducing in a plant the ability to produce seeds which remove chlorophyll under stress conditions, comprising modulating activity or expression in said plant or seeds of transcription factor ABA Insensitive 3 (ABI3) and/or chlorophyll degradation proteins Staygreen 1 (SGRl) or Staygreen 2 (SGR2), or a polypeptide having ABI3, SGRl or SGR2 activity.
  • ABSI3 transcription factor ABA Insensitive 3
  • SGRl chlorophyll degradation proteins
  • SGRl chlorophyll degradation proteins
  • the polypeptide may comprise an amino acid sequence with 60%, or 75%, or 80%, or 90%, or 95%, or even 99% identity to the amino acid sequence of SEQ ID NO: l, SEQ ID NO:3, SEQ ID NO:5 or SEQ ID NO:7.
  • certain non-limiting embodiments of the method may involve steps of: a) introducing into the plant a nucleic acid construct encoding at least one promoter operably linked to at least one nucleic acid that modulates expression of ABI3, SGRl or SGR2, or the polypeptide having ABI3, SGRl or SGR2 activity in said plant; and b) selecting for and regenerating and/or propagating the resulting transgenic plant.
  • the method may involve overexpressing ABI3, SGRl or SGR2, or the polypeptide having ABI3, SGRl or SGR2 activity, such that the expression level of the ABI3, SGRl, SGR2, or polypeptide having ABI3, SGRl or SGR2 activity is increased in the seeds of the modified plant as compared to expression levels of ABI3, SGRl, SGR2, or a polypeptide having ABI3, SGRl or SGR2 activity in seeds of unmodified plants.
  • the stress conditions may include cold temperatures, drought, heat, or osmotic stress.
  • transgenic plant produced according to the above method.
  • the plant may be one of the following types of crop species: canola, soybean, maize, wheat, rye, oat, triticale, rice, millet, sorghum, barley, peanut, cotton, rapeseed, manihot, pepper, sunflower, tagetes, solanaceous plants, potato, tobacco, eggplant, tomato, Vicia species, pea, alfalfa, coffee, cacao, tea, Salix species, oil palm, coconut, perennial grass, and forage crop plant.
  • Cells and seeds of the transgenic plants are also provided.
  • nucleic acid construct for inducing in a plant the ability to produce seeds which remove chlorophyll under stress conditions.
  • the nucleic acid construct comprises at least one promoter operably linked to at least one nucleic acid that modulates activity or expression of transcription factor ABA Insensitive 3 (ABI3) and/or chlorophyll degradation proteins Stay green 1 (SGR1) or Stay green 2 (SGR2), or a polypeptide having ABI3, SGR1 or SGR2 activity.
  • the polypeptide may comprise an amino acid sequence with 60%, or 75%, or 80%>, or 90%, or 95%, or even 99% identity to the amino acid sequence of SEQ ID NO: l, SEQ ID NO:3, SEQ ID NO:5 or SEQ ID NO:7.
  • the at least one nucleic acid may comprise a polynucleotide sequence having 60%, or 75%, or 80%, or 90%, or 95%, or even 99% identity to the polynucleotide sequence of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 or SEQ ID NO:8.
  • SEQ ID NO: l is the amino acid sequence of ABI3, and SEQ ID NO:2 is the DNA sequence of ABI3, in Arabidopsis thaliana.
  • SEQ ID NO:3 is the amino acid sequence of SGR1, and SEQ ID NO:4 is the DNA sequence of SGR1, in Arabidopsis thaliana.
  • SEQ ID NO:5 is the amino acid sequence of SGR2, and SEQ ID NO:6 is the DNA sequence of SGR2, in Arabidopsis thaliana.
  • SEQ ID NO:7 is the amino acid sequence of ABI3, and SEQ ID NO:8 is the DNA sequence of ABI3, in Brassica napus.
  • a DNA based molecule for carrying the described nucleic acid construct is also provided, including but not limited to plasmids and vectors.
  • Transgenic plant cells and transgenic tissue cultures comprising the above nucleic acid construct are also provided, as are transgenic plants regenerated and comprising the aforesaid plant cell or tissue culture.
  • the transgenic plant may, in certain embodiments, be either hemizygous or homozygous for the nucleic acid.
  • the transgenic plant may also be a monocot or a dicot.
  • the plant may be one of the following plant types: fruit-bearing plants, vegetable-bearing plants, plants used in the cut flower industry, grain-producing plants, oil- producing plants, nut-producing plants, crops including sugar beet, coffee, cacao, tea, soybean, cotton, flax, tobacco, pepper, perennial grasses, conifers and evergreens.
  • Plant seeds produced by the described transgenic plants are also provided, whereby the seeds comprise the nucleic acid construct.
  • the seed may also, in certain embodiments, be true breeding for producing plants with seeds that remove chlorophyll under stress conditions, as compared to a wild type variety of the seed.
  • FIG. 2 SGR1 and SGR2 are upregulated during seed maturation and are reduced in abi3-6 background.
  • A. Seed and mature embryo phenotypes of abi3-6 and abi3-8 mutants compared to Col-0 (Scale lmm)
  • Electrophoretic mobility shift assays of recombinant ABB B3 domain protein with 32 P-labelled probes derived from the SGR1 and SGR2 gene promoters. Competition experiments were performed using increasing amounts (10X, 100X, 1000X) of the SGR1/SGR2 unlabelled probes. The B3 -binding target sequence is shown below the autoradiographs.
  • FIG. 3 SGR1 and SGR2 overexpression rescues abi3-6 stay-green embryo phenotype. Phenotype of three representative lines (F, G, H) from abi3-6 / 35S..SGR1 (A) and abi3-6 / 35S..SGR2 (A, B, D) (B) showing rescue of embryo degreening. The respective RT-PCR analysis to verify SGR1 and SGR2 overexpression is shown below the figures.
  • C Seed desiccation tolerance assay. Mature seeds from Col-0, abi3-6 and the abi3-6/35S::SGR overexpressors (A,B,D,F,G,H) were stored for four weeks followed by stratification and germination on 0.5X MS plates to assess desiccation tolerance.
  • FIG. 4 SGRl and SGR2 play a redundant function in embryo de-greening Col-0, sgrl-1, sgr2-2 and sgrl-l/sgr2-2 mutants were analyzed for, A. SGRl and SGR2 expression at 16 DAF through either qRT-PCR (left) or RT-PCR (right). Values indicate levels of SGR2 transcripts relative to Col-0 B. Seed de-greening from 13 DAF to 17 DAF and at maturity (desiccated) in- planta C. chlorophyll accumulation in mature seeds D. ABA sensitivity (2 ⁇ and 10 ⁇ ABA) following storage for four weeks. Values are means ⁇ SEM of three biological replicates
  • FIG. 5 ABI3 overexpression rescues cold-induced green seeds in Arabidopsis.
  • A Mature seeds from Col-0 and ABI3 overexpressing (35S::ABI3/abi3-6) plants showing cold-induced effect on de-greening. Arabidopsis plants were exposed to -5 °C to -10°C (2 hours/day) for 1 to 3 days at various stages of pod development, followed by maintenance at ambient temperature (22°C). Following maturation, the seeds were harvested and observed for presence of green seeds.
  • ABI3 overexpression rescues cold-induced green seeds in Arabidopsis.
  • A Mature seeds from Col-0 and ABI3 overexpressing (35S::ABI3/abi3-6) plants showing cold-induced effect on de-greening. Arabidopsis plants were exposed to -5 °C to -10°C (2 hours/day) for 1 to 3 days at various stages of pod development, followed by maintenance at ambient temperature (22°C). Following maturation, the seeds were harvested and observed for presence of green seeds.
  • B Mature seeds from
  • FIG. 6 Genetic Network regulating embryo degreening in Arabidopsis. Embryo de-greening is exclusively orchestrated by ABI3. ABI3 controls embryo degreening through regulating transcription of functionally redundant SGRl (Mendel's / locus) and SGR2, which function downstream of ABI3 to mediate de-greening. This de-greening process is also partially coupled to ABA sensitivity. (Dashed arrows: Transcriptional regulation; Thin arrows: partial or lesser control).
  • Figure 7 A. Protein domains of ABI3 with the locations of the published mutations (modified from Nambara et al., 2002).
  • MapMan http ://www. abipd.org/proj ects/MapMan/ .
  • Figure 9 Vegetative phenotypes of abi3-6/35S::SGRl and abi3-6/35S::SGR2.
  • FIG. 10 Protein profiles were analyzed from mature seeds of Col-0, abi3-6 and abi3- 6/35S::SGR overexpressors A. Freshly harvested mature seeds from the transgenic lines were tested for ABA sensitivity by germinating them on 10 and 25 ⁇ ABA without stratification. Radicle emergence was observed at either 24h (B) or 72h (C) following plating. Values are means ⁇ SEM of three biological replicates. Germination index was measured as the ratio of % germination on treatment plates / % germination of abi3-6 on half strength MS plates.
  • Figure 11 Protein profiles were analyzed from mature seeds of Col-0, abi3-6, sgrl-1, sgr2-2 and sgrl-l/sgr2-2.
  • Figure 12 Induced senescence assay indicates a seed specific de-greening phenotype in abi3-6. Rosette phenotypes of Col-0, abi3-6, sgrl-1 and sgr2-2 homozygous T-DNA insertional lines after 7 days of dark-induced senescence.
  • Figure 14 Spring frost tolerance of KD29 a: ⁇ BnABI 3 canola plants. After treatment at -3 °C for 3 hours for 2 consecutive days, wild type (WT) plants have yellow leaves showing evidence of damaged tissue and plant death. Plants overexpressing ABI3 (RD29a: :BnABI3) remain viable with minimal or no signs of tissue damage after treatment (-3 °C, 3 hrs).
  • Figure 15 Fall frost tolerance of KD29a: :BnABI3 canola seeds.
  • WT and ABI3 overexpressing (RD29a: :BnABI3) plants were exposed to -6 °C for 4 hours, followed by maintenance at ambient temperature (22°C). Following maturation, the seeds were harvested and observed for presence of green seeds. Seeds were cut in half to show the seed interior after the outer coat was taken off. WT seeds have excessive chlorophyll and are shrivelled from the cold treatment.
  • the RD29a: :BnABI3 transgenic lines maintained their seed shape better and had increased ability to remove excess chlorophyll.
  • the present invention relates to a method for inducing in a plant the ability to produce seeds which remove chlorophyll under stress conditions.
  • the method comprises modulating activity or expression in seeds of the plant the transcription factor ABA Insensitive 3 (ABB) and/or chlorophyll degradation proteins Staygreen 1 (SGR1) or Staygreen 2 (SGR2), or a polypeptide having ABB, SGR1 or SGR2 activity.
  • ABB transcription factor ABA Insensitive 3
  • SGR1 chlorophyll degradation proteins
  • SGR2 chlorophyll degradation proteins
  • nucleic acid construct for inducing in a plant the ability to produce seeds which remove chlorophyll under stress conditions.
  • the nucleic acid construct comprises at least one promoter operably linked to at least one nucleic acid that modulates activity or expression of ABB, SGR1 or SGR2, or a polypeptide having ABB, SGR1 or SGR2 activity.
  • the stable inclusion of the nucleic acid construct in transgenic plants is also provided herein.
  • the transgenic plants have shown desirable phenotypic characteristics when compared to control plants, in particular, the ability to produce seeds which remove chlorophyll under stress conditions, such as cold temperatures or other environmental stresses.
  • transgenic plants produced by the methods of the invention or which comprise the described nucleic acid construct, and the seed produced by the plants which produce a plant that has an altered phenotype.
  • Nucleic acid molecule refers to an oligonucleotide, polynucleotide or any fragment thereof. It may be DNA or RNA of genomic or synthetic origin, double-stranded or single-stranded, and combined with carbohydrate, lipids, protein, or other materials to perform a particular activity such as transformation or form a useful composition such as a peptide nucleic acid (PNA).
  • PNA peptide nucleic acid
  • Polynucleotide is a nucleic acid molecule comprising a plurality of polymerized nucleotides, e.g., at least about 15 consecutive polymerized nucleotides.
  • a polynucleotide may be a nucleic acid, oligonucleotide, nucleotide, or any fragment thereof.
  • a polynucleotide comprises a nucleotide sequence encoding a polypeptide (or protein) or a domain or fragment thereof.
  • the polynucleotide may comprise a promoter, an intron, an enhancer region, a polyadenylation site, a translation initiation site, 5' or 3' untranslated regions, a reporter gene, a selectable marker, or the like.
  • the polynucleotide can be single-stranded or double- stranded DNA or RNA.
  • the polynucleotide optionally comprises modified bases or a modified backbone.
  • the polynucleotide can be, e.g., genomic DNA or RNA, a transcript (such as an mRNA), a cDNA, a PCR product, a cloned DNA, a synthetic DNA or RNA, or the like.
  • the polynucleotide can be combined with carbohydrate, lipids, protein, or other materials to perform a particular activity such as transformation or form a useful composition such as a peptide nucleic acid (PNA).
  • PNA peptide nucleic acid
  • the polynucleotide can comprise a sequence in either sense or antisense orientations. "Oligonucleotide” is substantially equivalent to the terms amplimer, primer, oligomer, element, target, and probe and is preferably single-stranded.
  • Gene refers to the partial or complete coding sequence of a gene, its complement, and its 5' or 3' untranslated regions.
  • a gene is also a functional unit of inheritance, and in physical terms is a particular segment or sequence of nucleotides along a molecule of DNA (or RNA, in the case of RNA viruses) involved in producing a polypeptide chain. The latter may be subjected to subsequent processing such as chemical modification and folding to obtain a functional protein or polypeptide.
  • a gene may be isolated, partially isolated, or be found with an organism's genome.
  • a transcription factor gene encodes a transcription factor polypeptide, which may be functional or require processing to function as an initiator of transcription.
  • genes may be defined by the cis-trans test, a genetic test that determines whether two mutations occur in the same gene and that may be used to determine the limits of the genetically active unit (Rieger et al. (1976) Glossary of Genetics and Cytogenetics: Classical and Molecular. 4th ed., Springer Verlag. Berlin).
  • a gene generally includes regions preceding ("leaders”; upstream) and following ("trailers”; downstream) the coding region.
  • a gene may also include intervening, non-coding sequences, referred to as "introns", located between individual coding segments, referred to as "exons". Most genes have an associated promoter region, a regulatory sequence 5' of the transcription initiation codon (there are some genes that do not have an identifiable promoter). The function of a gene may also be regulated by enhancers, operators, and other regulatory elements.
  • a "recombinant polynucleotide” is a polynucleotide that is not in its native state, e.g., the polynucleotide comprises a nucleotide sequence not found in nature, or the polynucleotide is in a context other than that in which it is naturally found, e.g., separated from nucleotide sequences with which it typically is in proximity in nature, or adjacent (or contiguous with) nucleotide sequences with which it typically is not in proximity.
  • the sequence at issue can be cloned into a vector, or otherwise recombined with one or more additional nucleic acid.
  • isolated polynucleotide is a polynucleotide, whether naturally occurring or recombinant, that is present outside the cell in which it is typically found in nature, whether purified or not.
  • an isolated polynucleotide is subject to one or more enrichment or purification procedures, e.g., cell lysis, extraction, centrifugation, precipitation, or the like.
  • “Fragment” refers to a clone or any part of a polynucleotide molecule that retains a usable, functional characteristic.
  • Useful fragments include oligonucleotides and polynucleotides that may be used in hybridization or amplification technologies or in the regulation of replication, transcription or translation.
  • a "polynucleotide fragment” refers to any subsequence of a polynucleotide, typically at least about nine or more consecutive nucleotides of any of the sequences provided herein.
  • Exemplary polynucleotide fragments are the first sixty consecutive nucleotides of the transcription factor polynucleotides listed in the Sequence Listing.
  • Exemplary fragments also include fragments that comprise a region that encodes an Al, B l, B2 or a B3 domain of a transcription factor.
  • Fragments may also include subsequences of polypeptides and protein molecules, or a subsequence of the polypeptide. Fragments may have uses in that they may have antigenic potential.
  • the fragment or domain is a subsequence of the polypeptide which performs at least one biological function of the intact polypeptide in substantially the same manner, or to a similar extent, as does the intact polypeptide.
  • a polypeptide fragment can comprise a recognizable structural motif or functional domain such as a DNA- binding site or domain that binds to a DNA promoter region, an activation domain, or a domain for protein-protein interactions, and may initiate transcription.
  • Fragments can vary in size from as few as 3 amino acid residues to the full length of the intact polypeptide, but are preferably at least about 30 amino acid residues in length.
  • Exemplary polypeptide fragments are the first twenty consecutive amino acids of a mammalian protein encoded by are the first twenty consecutive amino acids of the transcription factor polypeptides listed in the Sequence Listing.
  • the invention also encompasses production of DNA sequences that encode transcription factors and transcription factor derivatives, or fragments thereof, entirely by synthetic chemistry.
  • the synthetic sequence may be inserted into any of the many available expression vectors and cell systems using reagents well known in the art.
  • synthetic chemistry may be used to introduce mutations into a sequence encoding transcription factors or any fragment thereof.
  • polypeptide is an amino acid sequence comprising a plurality of consecutive polymerized amino acid residues e.g., at least about 15 consecutive polymerized amino acid residues.
  • a polypeptide comprises a polymerized amino acid residue sequence that is a transcription factor or a domain or portion or fragment thereof.
  • the polypeptide may comprise (i) a localization domain; (ii) an activation domain; (iii) a repression domain; (iv) an oligomerization domain; or (v) a DNA-binding domain, or the like.
  • the polypeptide optionally comprises modified amino acid residues, naturally occurring amino acid residues not encoded by a codon, or non-naturally occurring amino acid residues.
  • Protein refers to an amino acid sequence, oligopeptide, peptide, polypeptide or portions thereof whether naturally occurring or synthetic.
  • portion refers to any part of a polypeptide used for any purpose, including the screening of a library of molecules that specifically bind to that portion or for the production of antibodies.
  • a “recombinant polypeptide” is a polypeptide produced by translation of a recombinant polynucleotide.
  • a “synthetic polypeptide” is a polypeptide created by consecutive polymerization of isolated amino acid residues using methods well known in the art.
  • An “isolated polypeptide,” whether a naturally occurring or a recombinant polypeptide, is more enriched in (or out of) a cell than the polypeptide in its natural state in a wild-type cell, e.g., more than about 5% enriched relative to wild type standardized at 100%. Such an enrichment is not the result of a natural response of a wild-type plant.
  • the isolated polypeptide is separated from other cellular components with which it is typically associated, e.g., by any of the various protein purification methods herein.
  • Homology refers to sequence similarity between a reference sequence and at least a fragment of a newly sequenced clone insert or its encoded amino acid sequence.
  • Identity or similarity refers to sequence similarity between two polynucleotide sequences or between two polypeptide sequences, with identity being a more strict comparison.
  • the phrases “percent identity” and “% identity” refer to the percentage of sequence similarity found in a comparison of two or more polynucleotide sequences or two or more polypeptide sequences.
  • Sequence similarity refers to the percent similarity in base pair sequence (as determined by any suitable method) between two or more polynucleotide sequences. Two or more sequences can be anywhere from 0-100% similar, or any integer value there between. Identity or similarity can be determined by comparing a position in each sequence that may be aligned for purposes of comparison.
  • a degree of similarity or identity between polynucleotide sequences is a function of the number of identical similar or matching nucleotides at positions shared by the polynucleotide sequences.
  • a degree of identity of polypeptide sequences is a function of the number of identical amino acids at positions shared by the polypeptide sequences.
  • a degree of homology or similarity of polypeptide sequences is a function of the number of amino acids at positions shared by the polypeptide sequences.
  • the terms "substantial identity” or “substantially identical” may refer to sequences of sufficient similarity and structure to the transcription factors in the Sequence Listing to produce similar function when expressed or overexpressed in a plant; in the present invention, this function is increased tolerance to abiotic stress. Sequences that are at least about 80% identical, to the instant polypeptide sequences, including Al, B l, B2 and B3 domain sequences, are considered to have “substantial identity” with the latter. Sequences having lesser degrees of identity but comparable biological activity are considered to be equivalents. The structure required to maintain proper functionality is related to the tertiary structure of the polypeptide.
  • Substantial identity may thus also be used with regard to subsequences, for example, motifs, that are of sufficient structure and similarity, being at least about 80% identical to similar motifs in other related sequences so that each confers or is required for increased tolerance to abiotic stress.
  • “Alignment” refers to a number of nucleotide or amino acid residue sequences aligned by lengthwise comparison so that components in common (i.e., nucleotide bases or amino acid residues at corresponding positions) may be visually and readily identified. The fraction or percentage of components in common is related to the homology or identity between the sequences. An alignment may suitably be determined by means of computer programs known in the art, such as Mac Vector (1999) (Accelrys, Inc., San Diego, CA).
  • a “conserved domain” or “conserved region” as used herein refers to a region in heterologous polynucleotide or polypeptide sequences where there is a relatively high degree of sequence identity between the distinct sequences.
  • Al, Bl, B2 and B3 domains are examples of conserved domains.
  • a conserved domain is preferably at least 10 base pairs (bp) in length.
  • a “conserved domain”, with respect to presently disclosed polypeptides refers to a domain within a transcription factor family that exhibits a higher degree of sequence homology, such as at least 70% sequence similarity, including conservative substitutions, greater than about 70% identity, or at least about 79%, 81%, 86%, 87%, 89%, 91%, 95%, or 98% amino acid residue sequence identity of a polypeptide of consecutive amino acid residues.
  • a fragment or domain can be referred to as outside a conserved domain, outside a consensus sequence, or outside a consensus DNA-binding site that is known to exist or that exists for a particular transcription factor class, family, or subfamily. In this case, the fragment or domain will not include the exact amino acids of a consensus sequence or consensus DNA-binding site of a transcription factor class, family or sub-family, or the exact amino acids of a particular transcription factor consensus sequence or consensus DNA-binding site.
  • a particular fragment, region, or domain of a polypeptide, or a polynucleotide encoding a polypeptide can be "outside a conserved domain” if all the amino acids of the fragment, region, or domain fall outside of a defined conserved domain(s) for a polypeptide or protein. Sequences having lesser degrees of identity but comparable biological activity are considered to be equivalents.
  • conserved domains may be identified as regions or domains of identity to a specific consensus sequence (for example, Riechmann et al. (2000) Science 290: 2105-2110).
  • conserved domains i.e., Al, B l, B2 and B3 of the ABI3, SGR1 and SGR2 plant transcription factors (Riechmann and Meyerowitz (1998) Biol. Chem. 379:633-646) may be determined.
  • “Complementary” refers to the natural hydrogen bonding by base pairing between purines and pyrimidines.
  • sequence A-C-G-T (5' -> 3') forms hydrogen bonds with its complements A-C-G-T (5' -> 3') or A-C-G-U (5' -> 3').
  • Two single-stranded molecules may be considered partially complementary, if only some of the nucleotides bond, or "completely complementary” if all of the nucleotides bond. The degree of complementarity between nucleic acid strands affects the efficiency and strength of hybridization and amplification reactions.
  • Fully complementary refers to the case where bonding occurs between every base pair and its complement in a pair of sequences, and the two sequences have the same number of nucleotides.
  • highly stringent or “highly stringent condition” refer to conditions that permit hybridization of DNA strands whose sequences are highly complementary, wherein these same conditions exclude hybridization of significantly mismatched DNAs.
  • Polynucleotide sequences capable of hybridizing under stringent conditions with the polynucleotides of the present invention may be, for example, variants of the disclosed polynucleotide sequences, including allelic or splice variants, or sequences that encode orthologs or paralogs of presently disclosed polypeptides.
  • stringency is determined by the temperature, ionic strength, and concentration of denaturing agents (e.g., formamide) used in a hybridization and washing procedure (a more detailed description of establishing and determining stringency is presented below).
  • denaturing agents e.g., formamide
  • the degree to which two nucleic acids hybridize under various conditions of stringency is correlated with the extent of their similarity.
  • similar nucleic acid sequences from a variety of sources such as within a plant's genome (as in the case of paralogs) or from another plant (as in the case of orthologs) that may perform similar functions can be isolated on the basis of their ability to hybridize with known transcription factor sequences.
  • nucleic acid hybridization can be performed to isolate transcription factor sequences having similarity to transcription factor sequences known in the art and are not limited to those explicitly disclosed herein.
  • Such an approach may be used to isolate polynucleotide sequences having various degrees of similarity with disclosed transcription factor sequences, such as, for example, transcription factors having 60% or more identity with disclosed transcription factors.
  • homologous polynucleotide sequences and homologous polypeptide sequences may be paralogs or orthologs of the claimed polynucleotide or polypeptide sequences.
  • Orthologs and paralogs are evolutionarily-related genes that have similar sequence and similar functions.
  • Orthologs are structurally-related genes in different species that are derived by a speciation event.
  • Paralogs are structurally related genes within a single species that are derived by a duplication event.
  • Sequences that are sufficiently similar to one another will be appreciated by those of skill in the art and may be based upon percentage identity of the complete sequences, percentage identity of a conserved domain or sequence within the complete sequence, percentage similarity to the complete sequence, percentage similarity to a conserved domain or sequence within the complete sequence, and/or an arrangement of contiguous nucleotides or peptides particular to a conserved domain or complete sequence. Sequences that are sufficiently similar to one another will also bind in a similar manner to the same DNA binding sites of transcriptional regulatory elements using methods well-known to those of skill in the art.
  • equivalog describes members of a set of homologous proteins that are conserved with respect to function since their last common ancestor. Related proteins are grouped into equivalog families, and otherwise into protein families with other hierarchically defined homology types. This definition is provided at the Institute for Genomic Research (TIGR) world wide web (www) website, " tigr.org " under the heading "Terms associated with TIGRFAMs”.
  • TIGR Institute for Genomic Research
  • variant may refer to polynucleotides or polypeptides that differ from the presently disclosed polynucleotides or polypeptides, respectively, in sequence from each other, and as set forth below.
  • polynucleotide variants differences between presently disclosed polynucleotides and polynucleotide variants are limited so that the nucleotide sequences of the former and the latter are closely similar overall and, in many regions, identical. Due to the degeneracy of the genetic code, differences between the former and latter nucleotide sequences may be silent (i.e., the amino acids encoded by the polynucleotide are the same, and the variant polynucleotide sequence encodes the same amino acid sequence as the presently disclosed polynucleotide).
  • Variant nucleotide sequences may encode different amino acid sequences, in which case such nucleotide differences will result in amino acid substitutions, additions, deletions, insertions, truncations or fusions with respect to the similar disclosed polynucleotide sequences. These variations may result in polynucleotide variants encoding polypeptides that share at least one functional characteristic. The degeneracy of the genetic code also dictates that many different variant polynucleotides can encode identical and/or substantially similar polypeptides in addition to those sequences illustrated in the Sequence Listing.
  • a variant of a transcription factor nucleic acid listed in the Sequence Listing that is, one having a sequence that differs from the one of the polynucleotide sequences in the Sequence Listing, or a complementary sequence, that encodes a functionally equivalent polypeptide (i.e., a polypeptide having some degree of equivalent or similar biological activity) but differs in sequence from the sequence in the Sequence Listing, due to degeneracy in the genetic code.
  • polymorphisms that may or may not be readily detectable using a particular oligonucleotide probe of the polynucleotide encoding polypeptide, and improper or unexpected hybridization to allelic variants, with a locus other than the normal chromosomal locus for the polynucleotide sequence encoding polypeptide.
  • Allelic variant or polynucleotide allelic variant refers to any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variation arises naturally through mutation, and may result in phenotypic polymorphism within populations. Gene mutations may be "silent” or may encode polypeptides having altered amino acid sequence. "Allelic variant” and “polypeptide allelic variant” may also be used with respect to polypeptides, and in this case the terms refer to a polypeptide encoded by an allelic variant of a gene.
  • splice variant or “polynucleotide splice variant” as used herein refers to alternative forms of RNA transcribed from a gene. Splice variation naturally occurs as a result of alternative sites being spliced within a single transcribed RNA molecule or between separately transcribed RNA molecules, and may result in several different forms of mRNA transcribed from the same gene. Thus, splice variants may encode polypeptides having different amino acid sequences, which may or may not have similar functions in the organism. "Splice variant” or “polypeptide splice variant” may also refer to a polypeptide encoded by a splice variant of a transcribed mRNA.
  • polynucleotide variants may also refer to polynucleotide sequences that encode paralogs and orthologs of the presently disclosed polypeptide sequences.
  • Polypeptide variants may refer to polypeptide sequences that are paralogs and orthologs of the presently disclosed polypeptide sequences.
  • a polypeptide sequence variant may have "conservative" changes, wherein a substituted amino acid has similar structural or chemical properties. Deliberate amino acid substitutions may thus be made on the basis of similarity in polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the residues, as long as a substantial amount of the functional or biological activity of the transcription factor is retained.
  • negatively charged amino acids may include aspartic acid and glutamic acid
  • positively charged amino acids may include lysine and arginine
  • amino acids with uncharged polar head groups having similar hydrophilicity values may include leucine, isoleucine, and valine; glycine and alanine; asparagine and glutamine; serine and threonine; and phenylalanine and tyrosine.
  • a variant may have "non-conservative" changes, for example, replacement of a glycine with a tryptophan.
  • Similar minor variations may also include amino acid deletions or insertions, or both.
  • Related polypeptides may comprise, for example, additions and/or deletions of one or more N-linked or O-linked glycosylation sites, or an addition and/or a deletion of one or more cysteine residues.
  • Guidance in determining which and how many amino acid residues may be substituted, inserted or deleted without abolishing functional or biological activity may be found using computer programs well known in the art, for example, DNASTAR software (for example, in US 5,840,544).
  • “Modulates” refers to a change in activity or expression level (e.g. overexpression) of a polypeptide or nucleic acid as compared to wild type activity or expression of the same polypeptide or nucleic acid.
  • plant includes whole plants, shoot vegetative organs/structures (for example, leaves, stems and tubers), roots, flowers and floral organs/structures (for example, bracts, sepals, petals, stamens, carpels, anthers and ovules), seed (including embryo, endosperm, and seed coat) and fruit (the mature ovary), plant tissue (for example, vascular tissue, ground tissue, and the like) and cells (for example, guard cells, egg cells, and the like), and progeny of same.
  • the class of plants that can be used in the method of the invention is generally as broad as the class of higher and lower plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), gymnosperms, ferns, horsetails, psilophytes, lycophytes, bryophytes, and multicellular algae.
  • angiosperms monocotyledonous and dicotyledonous plants
  • gymnosperms gymnosperms
  • ferns ferns
  • horsetails psilophytes, lycophytes, bryophytes, and multicellular algae.
  • a "transgenic plant” refers to a plant that contains genetic material not found in a wild-type plant of the same species, variety or cultivar.
  • the genetic material may include a transgene, an insertional mutagenesis event (such as by transposon or T-DNA insertional mutagenesis), an activation tagging sequence, a mutated sequence, a homologous recombination event or a sequence modified by chimeraplasty.
  • the foreign genetic material has been introduced into the plant by human manipulation, but any method can be used as one of skill in the art recognizes.
  • a transgenic plant may contain an expression vector or cassette.
  • the expression vector or cassette typically comprises a polypeptide-encoding sequence operably linked (i.e., under regulatory control of) to appropriate inducible or constitutive regulatory sequences that allow for the expression of polypeptide.
  • the expression vector or cassette can be introduced into a plant by transformation or by breeding after transformation of a parent plant.
  • a plant refers to a whole plant as well as to a plant part, such as seed, fruit, leaf, or root, plant tissue, plant cells or any other plant material, for example, a plant explant, as well as to progeny thereof, and to in vitro systems that mimic biochemical or cellular components or processes in a cell.
  • Wild type or wild-type, as used herein, refers to a plant cell, seed, plant component, plant tissue, plant organ or whole plant that has not been genetically modified or treated in an experimental sense. Wild-type cells, seed, components, tissue, organs or whole plants may be used as controls to compare levels of expression and the extent and nature of trait modification with cells, tissue or plants of the same species in which a transcription factor expression is altered, e.g., in that it has been knocked out, overexpressed, or ectopically expressed.
  • control plant refers to a plant cell, seed, plant component, plant tissue, plant organ or whole plant used to compare against transgenic or genetically modified plant for the purpose of identifying an enhanced phenotype in the transgenic or genetically modified plant.
  • a control plant may in some cases be a transgenic plant line that comprises an empty vector or marker gene, but does not contain the recombinant polynucleotide of the present invention that is expressed in the transgenic or genetically modified plant being evaluated.
  • a control plant is a plant of the same line or variety as the transgenic or genetically modified plant being tested.
  • a suitable control plant would include a genetically unaltered or non-transgenic plant of the parental line used to generate a transgenic plant herein.
  • “Derivative” refers to the chemical modification of a nucleic acid molecule or amino acid sequence. Chemical modifications can include replacement of hydrogen by an alkyl, acyl, or amino group or glycosylation, pegylation, or any similar process that retains or enhances biological activity or lifespan of the molecule or sequence.
  • a “trait” refers to a physiological, morphological, biochemical, or physical characteristic of a plant or particular plant material or cell. In some instances, this characteristic is visible to the human eye, such as seed or plant size, or can be measured by biochemical techniques, such as detecting the protein, starch, or oil content of seed or leaves, or by observation of a metabolic or physiological process, e.g. by measuring tolerance to water deprivation or particular salt or sugar concentrations, or by the observation of the expression level of a gene or genes, for example, by employing Northern analysis, RT-PCR, microarray gene expression assays, or reporter gene expression systems, or by agricultural observations such as abiotic stress tolerance or yield. Any technique can be used to measure the amount of, comparative level of, or difference in any selected chemical compound or macromolecule in the transgenic plants, however.
  • Trait modification refers to a detectable difference in a characteristic in a plant ectopically expressing a polynucleotide or polypeptide of the present invention relative to a plant not doing so, such as a wild-type plant.
  • the trait modification can be evaluated quantitatively.
  • the trait modification can entail at least about a 2% increase or decrease in an observed trait or an even greater difference, compared with a wild-type plant. It is known that there can be a natural variation in the modified trait. Therefore, the trait modification observed entails a change of the normal distribution and magnitude of the trait in the plants compared with the distribution and magnitude observed in wild-type plants.
  • plants When two or more plants have “similar morphologies”, “substantially similar morphologies” or “a morphology that is substantially similar”, the plants have comparable forms or appearances, including analogous features such as overall dimensions, height, width, mass, root mass, shape, glossiness, color, stem diameter, leaf size, leaf dimension, leaf density, internode distance, branching, root branching, number and form of inflorescences, and other macroscopic characteristics, and the genotypes of the plants with similar morphologies are not readily distinguishable based on morphological characteristics alone.
  • transcript profile refers to the expression levels of a set of genes in a cell in a particular state, particularly by comparison with the expression levels of that same set of genes in a cell of the same type in a reference state.
  • transcript profile of a particular transcription factor in a suspension cell is the expression levels of a set of genes in a cell repressing or overexpressing that transcription factor compared with the expression levels of that same set of genes in a suspension cell that has normal levels of that transcription factor.
  • the transcript profile can be presented as a list of those genes whose expression level is significantly different between the two treatments, and the difference ratios. Differences and similarities between expression levels may also be evaluated and calculated using statistical and clustering methods.
  • Ectopic expression or altered expression in reference to a polynucleotide indicates that the pattern of expression in, for example, a transgenic plant or plant tissue, is different from the expression pattern in a wild-type plant or a reference plant of the same species.
  • the pattern of expression may also be compared with a reference expression pattern in a wild-type plant of the same species.
  • the polynucleotide or polypeptide is expressed in a cell or tissue type other than a cell or tissue type in which the sequence is expressed in the wild-type plant, or by expression at a time other than at the time the sequence is expressed in the wild-type plant, or by a response to different inducible agents, such as hormones or environmental signals, or at different expression levels (either higher or lower) compared with those found in a wild-type plant.
  • the term also refers to altered expression patterns that are produced by lowering the levels of expression to below the detection level or completely abolishing expression.
  • the resulting expression pattern can be transient or stable, constitutive or inducible.
  • the term "ectopic expression or altered expression” further may relate to altered activity levels resulting from the interactions of the polypeptides with exogenous or endogenous modulators or from interactions with factors or as a result of the chemical modification of the polypeptides.
  • overexpression refers to a greater expression level of a gene in a plant, plant cell or plant tissue, compared to expression in a wild-type plant, cell or tissue, at any developmental or temporal stage for the gene. Overexpression can occur when, for example, the genes encoding one or more transcription factors are under the control of a strong promoter described herein (for example, the cauliflower mosaic virus 35 S transcription initiation region) or be induced when an appropriate environmental signal is present. Overexpression may occur throughout a plant or in specific tissues of the plant, depending on the promoter used, as described below. Overexpression may take place in plant cells normally lacking expression of polypeptides functionally equivalent or identical to the present transcription factors.
  • Overexpression may also occur in plant cells where endogenous expression of the present transcription factors or functionally equivalent molecules normally occurs, but such normal expression is at a lower level. Overexpression thus results in a greater than normal production, or "overproduction" of the transcription factor in the plant, cell or tissue.
  • transcription regulating region refers to a DNA regulatory sequence that regulates expression of one or more genes in a plant when a transcription factor having one or more specific binding domains binds to the DNA regulatory sequence.
  • Transcription factors of the present invention possess an Al, Bl, B2 and B3 domain (i.e. ABI3), or a Stay green superfamily (pfam: 12638) domain (i.e. SGR1 and SGR2).
  • ABI3 Al, Bl, B2 and B3 domain
  • pfam: 12638 domain i.e. SGR1 and SGR2
  • sample with respect to a material containing nucleic acid molecules may comprise a bodily fluid; an extract from a cell, chromosome, organelle, or membrane isolated from a cell; genomic DNA, RNA, or cDNA in solution or bound to a substrate; a cell; a tissue; a tissue print; a forensic sample; and the like.
  • substrate refers to any rigid or semi-rigid support to which nucleic acid molecules or proteins are bound and includes membranes, filters, chips, slides, wafers, fibers, magnetic or nonmagnetic beads, gels, capillaries or other tubing, plates, polymers, and microparticles with a variety of surface forms including wells, trenches, pins, channels and pores.
  • a substrate may also refer to a reactant in a chemical or biological reaction, or a substance acted upon (for example, by an enzyme).
  • a transcription factor may include, but is not limited to, any polypeptide that can activate or repress transcription of a single gene or a number of genes.
  • transcription factors can be identified by the presence of a region or domain of structural similarity or identity to a specific consensus sequence or the presence of a specific consensus DNA-binding site or DNA-binding site motif (for example, Riechmann et al. (2000) supra).
  • the transcription factors encoded by the present sequences are involved in various aspects of plant development. Accordingly, one skilled in the art would recognize that by expressing the present sequences in a plant, one may change the expression of autologous genes or induce the expression of introduced genes. By affecting the expression of similar autologous sequences in a plant that have the biological activity of the present sequences, or by introducing the present sequences into a plant, one may alter a plant's phenotype to one with improved traits related to environmental stresses, such as but not limited to cold.
  • the sequences of the invention may also be used to transform a plant and introduce desirable traits not found in the wild-type cultivar or strain. Plants may then be selected for those that produce the most desirable degree of over- or under-expression of target genes of interest and coincident trait improvement.
  • sequences of the present invention may be from any species, particularly plant species, in a naturally occurring form or from any source whether natural, synthetic, semi -synthetic or recombinant.
  • sequences of the invention may also include fragments of the present amino acid sequences.
  • amino acid sequence is recited to refer to an amino acid sequence of a naturally occurring protein molecule, "amino acid sequence” and like terms are not meant to limit the amino acid sequence to the complete native amino acid sequence associated with the recited protein molecule.
  • the polynucleotides and polypeptides of the invention have a variety of additional uses. These uses include their use in the recombinant production (i.e., expression) of proteins; as regulators of plant gene expression, as diagnostic probes for the presence of complementary or partially complementary nucleic acids (including for detection of natural coding nucleic acids); as substrates for further reactions, for example, mutation reactions, PCR reactions, or the like; as substrates for cloning for example, including digestion or ligation reactions; and for identifying exogenous or endogenous modulators of the transcription factors.
  • a polynucleotide comprises a nucleotide sequence encoding a polypeptide (or protein) or a domain or fragment thereof. Additionally, the polynucleotide may comprise a promoter, an intron, an enhancer region, a polyadenylation site, a translation initiation site, 5' or 3' untranslated regions, a reporter gene, a selectable marker, or the like.
  • the polynucleotide can be single-stranded or double-stranded DNA or RNA.
  • the polynucleotide optionally comprises modified bases or a modified backbone.
  • the polynucleotide can be, for example, genomic DNA or RNA, a transcript (such as an mRNA), a cDNA, a PCR product, a cloned DNA, a synthetic DNA or RNA, or the like.
  • the polynucleotide can comprise a sequence in either sense or antisense orientations.
  • transgenic plants comprising isolated polynucleotides encoding transcription factors may also modify expression of endogenous genes, polynucleotides, and proteins.
  • Examples include Peng et al. (1997) Genes Development 11 :3194-3205, and Peng et al. (1999) Nature, 400:256-261.
  • Peng et al. 1997) Genes Development 11 :3194-3205
  • Peng et al. (1999) Nature, 400:256-261
  • an Arabidopsis transcription factor expressed in an exogenous plant species elicits the same or very similar phenotypic response (for example, Fu et al. (2001) Plant Cell 13 : 1791-1802; Nandi et al. (2000) Curr. Biol. 10:215-218; Coupland (1995) Nature 377:482-483; and Weigel and Nilsson (1995) Nature 377:482-500).
  • Gilmour et al. (1998) Plant J. 16: 433-442, teach an Arabidopsis AP2 transcription factor, CBF1 that, when overexpressed in transgenic plants, increases plant freezing tolerance.
  • Jaglo et al. (2001 ) Plant Physiol. 127: 910-917, further identified sequences in Brassica napus which encode CBF-like genes and that transcripts for these genes accumulated rapidly in response to low temperature. Transcripts encoding CBF-like proteins were also found to accumulate rapidly in response to low temperature in wheat, as well as in tomato. An alignment of the CBF proteins from Arabidopsis, B.
  • Transcription factors mediate cellular responses and control traits through altered expression of genes containing cis-acting nucleotide sequences that are targets of the introduced transcription factor. It is well appreciated in the art that the effect of a transcription factor on cellular responses or a cellular trait is determined by the particular genes whose expression is either directly or indirectly (for example, by a cascade of transcription factor binding events and transcriptional changes) altered by transcription factor binding. In a global analysis of transcription comparing a standard condition with one in which a transcription factor is overexpressed, the resulting transcript profile associated with transcription factor overexpression is related to the trait or cellular process controlled by that transcription factor.
  • the PAP2 gene (and other genes in the MYB family) have been shown to control anthocyanin biosynthesis through regulation of the expression of genes known to be involved in the anthocyanin biosynthetic pathway (Bruce et al. (2000) Plant Cell, 12: 65-79; Borevitz et al. (2000) Plant Cell 12: 2383-93). Further, global transcript profiles have been used successfully as diagnostic tools for specific cellular states (for example, cancerous vs. non-cancerous; Bhattacharjee et al. (2001) Proc Natl. Acad. Sci., USA, 98: 13790-13795; Xu et al. (2001) Proc. Natl. Acad. Sci., USA, 98: 15089-15094).
  • TFs transcription factors
  • transcription factor homolog polypeptides isolated or recombinant polynucleotides encoding the polypeptides, or novel sequence variant polypeptides or polynucleotides encoding novel variants of transcription factors derived from the specific sequences provided here.
  • TFs transcription factors
  • transcription factor homolog polypeptides isolated or recombinant polynucleotides encoding the polypeptides, or novel sequence variant polypeptides or polynucleotides encoding novel variants of transcription factors derived from the specific sequences provided here.
  • These polypeptides and polynucleotides may be employed to modify a plant's characteristics.
  • polynucleotides described herein can be or were ectopically expressed in overexpressor or knockout plants and the changes in the characteristic(s) or trait(s) of the plants observed. Therefore, the polynucleotides and polypeptides can be employed to improve the characteristics of plants.
  • polynucleotides described herein can be or were ectopically expressed in overexpressor plant cells and the changes in the expression levels of a number of genes, polynucleotides, and/or proteins of the plant cells observed. Therefore, the polynucleotides and polypeptides can be employed to change expression levels of a genes, polynucleotides, and/or proteins of plants.
  • ABI3 was initially identified by mutational analysis and found to encode a protein with high homology to the maize seed-specific transcription factor VP1 (Giraudat et al., 1992). Additional Orthologs of ABI3 have since been found in a number of species including canola, Phaseolis vulgaris, rice, Avena fatua, the resurrection plant Craterostigma plantagineum Hochst, carrot, sorghum, poplar and yellow cedar (Koornneef et al., 1984, Finkelstein et al., 1990; Bobb et al., 1995; Jones et al., 2000; Chandler and Battels, 1997; Shiota et al., 1998, Rohde et al., 2000; Carrari et al., 2000; Lazarova et al., 2001; Zeng et al., 2003).
  • ABB protein binds to the highly conserved RY motif [DNA motif CATGCA(TG)], present in many seed-specific promoters, and the B3 domains of this transcription factor is necessary for the specific interaction with the RY element.
  • Transcriptional activity of ABI3 requires the B3 DNA-binding domain and an activation domain.
  • a second transcription activation domain was found in the Bl region of ABI3.
  • ABI3 is essential for seed maturation, a regulator of the transition between embryo maturation and early seedling development, and a putative seed-specific transcriptional activator. Mutants exhibit decreased responsiveness to ABA suggesting that ABI3 protein participates in the ABA perception/transduction cascade.
  • ABI3 interacts genetically with both FUS3 and LEC1 and is involved in controlling accumulation of chlorophyll and anthocyanins, sensitivity to abscisic acid, and expression of the members of the 12S storage protein gene family.
  • both FUS3 and LEC1 regulate positively the abundance of the ABI3 protein in the seed.
  • Alternative splicing of ABI3 is developmentally regulated by SUA (AT3G54230).
  • SUA AT3G54230
  • VP1/ABI3 has been shown to have a modular structure with respect to both protein and promoter sequences.
  • ABI3 may have functions outside of modulating ABA seed sensitivity.
  • ABI3 appears to play a role in plastid development and interacts with genes involved in light regulation (Rohde et al., 2000; Rohde et al., 2002).
  • ABI3 expression is detected in many quiescent tissues including the receptacle of flowers, the axils of pedicels and axillary flower bracts, the abscission zone of siliques and rosette leaves, and stipules (Parcy et al., 1994; Rohde et al., 1999).
  • the first domain implicated in such a function was the VPl B3 domain, which in isolation could specifically bind a RY cis-element common in many seed-specific promoters (Suzuki et al, 1997).
  • larger VPl protein variants that included flanking regions were unable to efficiently bind DNA, raising the possibility that interactions between protein domains may regulate VPl -DNA interaction in vivo (Suzuki et al, 1997).
  • Indirect evidence for a role of the ABI3 B3 domain in DNA-binding was demonstrated from transactivation studies which showed that the B3 domain was necessary for up-regulation of an RY-containing NAPIN promoter derivative (Ezcurra et al, 2000).
  • ABB protein Eventually a full-length ABB protein was shown to be capable of binding the RY element, and its B3 domain was both necessary and sufficient for mediating this specific interaction (Monke et al., 2004).
  • This conserved B3 activity has been shown for a variety of developmentally-important transcription factors including FUS3 (Reidt et al, 2000), LEC2 (Braybrook et al, 2006), ARF family members (Ulmasov et al, 1997; Ulmasov et al, 1999) and RAVI (Kagaya et al, 1999; Hu et al., 2004).
  • AIPs AB 13 -interacting proteins
  • the Bl domain of ABI3 has been shown to interact with ABI5 (Nakamura et al, 2001). This interaction appears to be evolutionarily conserved since the rice homolog OsVPl has also been shown to interact via the Bl and B2 domains with the ABI5 homolog TRABl in a yeast two- hybrid screen (Hobo et al, 1999). Finally, single-celled transient expression assays have shown that the Bl domain may also play a role in transcriptional activation, as its deletion greatly reduced the AB 13 -mediated induction of a target reporter gene (Monke et al, 2004).
  • RY motif CATGCATG (Baumlein et al. 1992 ; Bobb et al. 1997 ; Chamberland et al. 1992 ; Dickinson et al. 1988 ; Fujiwara & Beachy 1994; Lelievre et al. 1992 ).
  • This motif is widely distributed in seed-specific gene promoters of dicots and monocots including the promoters of the V. faba legumin and USP genes ( Baumlein et al. 1991a ; Baumlein et al. 1986 ; Fiedler et al. 1993 ), as well as the regulatory region of Brassica napus napin genes (Ellerstrom et al.
  • the RY motif represents the central core of the 28 bp legumin box (Baumlein et al. 1986), and its deletion abolishes most of the seed-specific promoter activity and results in low-level expression in leaves (Baumlein et al. 1992). Also in the napin promoter, the destruction of two RY motifs drastically reduces promoter activity (Ellerstrom et al. 1996 ; Stalberg et al. 1993). Together these data and the analysis of several other seed- specific promoters (see Morton et al. 1995) clearly demonstrate the importance of the RY motif for high-level expression of several seed-specific genes as well as the potential of this motif to function as a negative element repressing expression in non-seed tissues.
  • ABSCISIC ACID INSENSITIVE ABSCISIC ACID INSENSITIVE (ABI3) protein and its maize ortholog VIVIPAROUS 1 (VP1) regulate seed development and dormancy in response to abscisic acid (McCarty et al (1991) Cell 66: 895-905; Giraudat et al. (1992) Plant Cell 4: 1251-1261).
  • ABI3 (G621) and VP1 play an important role in the acquisition of desiccation tolerance in late embryogenesis. This process is related to dehydration tolerance as evidenced by the protective function of late embryogenesis abundant (LEA) genes such as HVA1 (Xu et al. (1996) Plant Physiol.
  • ABI3/VP1 Regulation by ABI3/VP1 is complex: the protein is a multidomain transcription factor that can apparently function as either an activator or a repressor depending on the promoter context (McCarty et al. (1991) supra; Hattori et al., (1992) Genes Dev. 6: 609-618; Hoecker et al. (1995) Genes Dev. 9: 2459-2469; Nambara et al. (1995) Development 121 : 629-636).
  • ABI3/VP1 has two other protein domains (the Bl and B2 domains) that are also highly conserved among ABI3/VP1 factors from various plant species (McCarty et al. (1991) supra).
  • the B3 domain of ABI3/VP1 binds the RY/SPH motif (Ezcurra et al. (2000) Plant J. 24: 57-66, Carson et al. (1997) supra), whereas the N terminal Bl and B2 domains are implicated in nuclear localization and interactions with other proteins.
  • the B2 domain is thought to act via ABA response elements (ABREs) in target promoters.
  • ABREs ABA response elements
  • VPI has been shown to activate ABREs through a core ACGT motif (called the G-Box), but does not bind the element directly.
  • the RY/SPH element is a key element in gene regulation during late embryogenesis in Arabidopsis (see also Reidt et al. (2000) Plant J. 21 : 401-408) while it seems to be less important for seed maturation in maize (McCarty et al. (1989) supra).
  • the B3 superfamily currently includes 363 members from various plant species, grouped into 16 distinct structural architectures based on their association with other conserved domain combinations (Bateman et al. 2004).
  • Arabidopsis FUSCA3 FUS3
  • the FUS3 protein can be considered as a natural truncation of the ABI3 protein (Luerssen et al. (1998) Plant J.
  • FUS3 binds to the RY/SPH element, and can activate expression from target promoters even in non-seed tissues (Reidt et al. (2000) supra).
  • AB3 domain is also present in LEAFY COTYLEDON 2 (Luerssen et al. (1998) supra; Stone et al. (2001) Proc. Natl. Acad. Sci. USA 98: 11806-11811).
  • ABI3, FUS3, LEC2, and LEAFY COTYLEDON I are known to act together to regulate many aspects of seed maturation (Parcy et al. (1997) Plant Cell 9: 1265-1277; Parcy and Giraudat (1997) Plant J. 11 : 693702; Wobus and
  • the B3 domain is present in several transcription factor families: RAV, ABI3/VP1, and ARF. It has been shown for all three families that the B3 domain is sufficient for DNA binding (Table 1).
  • B3 domains within the ARF class are 72% identical on average.
  • RAV-like and ABI3/VPl-like proteins average 64% identity within their subfamilies (Walther et al., Protein Sci. 2005 September; 14(9): 2478-2483).
  • the binding specificity varies significantly, these differences in the target specificity are also reflected at the protein level.
  • all B3 domains share certain conserved amino acids, there is significant variation between families. Despite the fact that the B3 domain can bind DNA autonomously (Kagaya et al. (1999) supra; Suzuki et al. (1997) Plant Cell 9: 799-807), in general, B3 domain transcription factors interact with their targets via two DNA binding domains (Table 1).
  • the second domain is located on the same protein. It has been shown for ABI3 that cooperative binding not only increases the specificity but also the affinity (Ezcurra et al. (2000) Plant J. 24: 57-66).
  • the structure of the B3 domain has been determined and found to consist of a seven- stranded ⁇ -sheet arranged in an open barrel and two short a-helices, one at each end of the barrel.
  • one of these 3D structures was the B3 domain of Atlgl6640, which is quite distinct from previously characterized B3 domain proteins in terms of amino acid sequence similarity, however it adopts the same novel fold that was revealed by the RAVI B3 domain structure.
  • RAVI and Atlgl6640 despite their structural similarity, share only 26% sequence identity.
  • Atlgl6640 shows similarly weak homology to the other two classes, sharing only approximately 22% and 20% identity with ARFs and ABI3/VP1- like proteins, respectively (Poirot et al. 2004). It suggests that this novel 3D fold is highly conserved among family members, despite relatively low sequence conservation.
  • polynucleotides described herein include sequences that encode transcription factors and transcription factor homolog polypeptides and sequences complementary thereto, as well as unique fragments of coding sequence, or sequences complementary thereto.
  • Such polynucleotides can be, for example, DNA or RNA, the latter including mRNA, cRNA, synthetic RNA, genomic DNA, cDNA synthetic DNA, oligonucleotides, etc.
  • the polynucleotides are either double-stranded or single-stranded, and include either, or both sense (i.e. coding) sequences and antisense (i.e. non-coding, complementary) sequences.
  • the polynucleotides include the coding sequence of a transcription factor, or transcription factor homolog polypeptide, in isolation, in combination with additional coding sequences (e.g., a purification tag, a localization signal, as a fusion-protein, as a pre-protein, or the like), in combination with non-coding sequences (for example, introns or inteins, regulatory elements such as promoters, enhancers, terminators, and the like), and or in a vector or host environment in which the polynucleotide encoding a transcription factor or transcription factor homolog polypeptide is an endogenous or exogenous gene.
  • additional coding sequences e.g., a purification tag, a localization signal, as a fusion-protein, as a pre-protein, or the like
  • non-coding sequences for example, introns or inteins, regulatory elements such as promoters, enhancers, terminators, and the like
  • polynucleotides of the invention can be produced by a variety of in vitro amplification methods adapted to the present invention by appropriate selection of specific or degenerate primers.
  • protocols sufficient to direct persons of skill through in vitro amplification methods include polymerase chain reaction (PCR), ligase chain reaction (LCR), QP-replicase amplification and other RNA polymerase mediated techniques (for example, NASBA), e.g., for the production of the homologous nucleic acids of the invention are found in Berger (supra), Sambrook (supra), and Ausubel (supra), as well as Mullis et al. (1987) PCR Protocols A Guide to Methods and Applications, Innis et al.
  • RNA can be converted into a double-stranded DNA suitable for restriction digestion, PCR expansion and sequencing using reverse transcriptase and a polymerase (for example, Ausubel, Sambrook and Berger, all supra).
  • polynucleotides and oligonucleotides can be assembled from fragments produced by solid-phase synthesis methods. Typically, fragments of up to approximately 100 bases are individually synthesized and then enzymatically or chemically ligated to produce a desired sequence, e.g., a polynucleotide encoding all or part of a transcription factor. For example, chemical synthesis using the phosphoramidite method is described, e.g., by Beaucage et al. (1981) Tetrahedron Letters 22: 1859-1869; and Matthes et al. (1984) EMBOJ. 3 : 801-805.
  • oligonucleotides are synthesized, purified, annealed to their complementary strand, ligated and then optionally cloned into suitable vectors. And if so desired, the polynucleotides and polypeptides of the invention can be custom ordered from any of a number of commercial suppliers.
  • homologous sequences can be derived from any plant including monocots and dicots and in particular agriculturally important plant species, including but not limited to, crops such as soybean, wheat, corn (maize), potato, cotton, rice, rape, oilseed rape (including canola), sunflower, alfalfa, clover, sugarcane, and turf; or fruits or fruit trees, vegetables such as banana, blackberry, blueberry, strawberry, and raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, tomatillo, watermelon, rosaceous fruits (such as apple, peach, pear, cherry and plum) and
  • Other crops including fruits and vegetables, whose phenotype can be changed and which comprise homologous sequences include barley; rye; millet; sorghum; currant; avocado; citrus fruits such as oranges, lemons, grapefruit and tangerines, artichoke, cherries; nuts such as the walnut and peanut; endive; leek; roots such as arrowroot, beet, cassava, turnip, radish, yam, and sweet potato; and beans.
  • the homologous sequences may also be derived from woody species, such as pine, poplar and eucalyptus, or mint or other labiates.
  • homologous sequences may be derived from plants that are evolutionarily related to crop plants, but which may not have yet been used as crop plants. Examples include deadly nightshade ⁇ Atropa belladona), related to tomato; jimson weed (Datura strommium), related to peyote; and teosinte (Zea species), related to corn (maize).
  • Homologous sequences as described above can comprise orthologous or paralogous sequences.
  • orthologs and paralogs are described; an ortholog, paralog or homolog may be identified by one or more of the methods described below.
  • gene duplication may cause two copies of a particular gene, giving rise to two or more genes with similar sequence, and are known as paralogs.
  • a paralog is therefore a similar gene formed by duplication within the same species.
  • Paralogous genes may retain similar functions of the encoded proteins.
  • paralogs can be used interchangeably with respect to certain embodiments of the instant invention (for example, transgenic expression of a coding sequence).
  • An excellent example of related paralogs includes the CBF family, with three well-defined members in Arabidopsis and one ortholog in Brassica napus, all of which control pathways involved in both freezing and drought stress (Gilmour et al. (1998) Plant J. 16: 433-442; Jaglo et al. (1998) Plant Physiol. Ill: 910-917).
  • Paralogs typically cluster together or in the same clade (a group of similar genes) when a gene family phylogeny is analyzed using programs such as CLUSTAL (Thompson et al. (1994) Nucleic Acids Res. 22: 4673-4680; Higgins et al. (1996) Methods Enzymol. 266: 383-402). Groups of similar genes can also be identified with pair-wise BLAST analysis (Feng and Doolittle (1987) J. Mol. Evol. 25: 351-360). For example, a clade of very similar MADS domain transcription factors from Arabidopsis all share a common function in flowering time (Ratcliffe et al. (2001) Plant Physiol.
  • Distinct Arabidopsis transcription factors including G28 (found in US Patent 6,664,446), G482 (found in US Patent Application 2004/0045049), G867 (found in US Patent Application 2004/0098764), and G1073 (found in US Patent 6,717,034), have been shown to confer stress tolerance or increased biomass when the sequences are overexpressed.
  • the polypeptides sequences belong to distinct clades of transcription factor polypeptides that include members from diverse species. In each case, a significant number of clade member sequences derived from both dicots and monocots have been shown to confer increased biomass or tolerance to stress when the sequences were overexpressed (unpublished data).
  • SAR systemic acquired resistance
  • the transgenic plants displayed enhanced resistance Choern et al. (2001) Plant J. 27: 101-113).
  • PR1 acts through activation of expression of transcription factor genes, such as TGA2 (Fan and Dong (2002) Plant Cell 14: 1377-1389).
  • E2F genes are involved in transcription of plant genes for proliferating cell nuclear antigen (PCNA). Plant E2Fs share a high degree of similarity in amino acid sequence between monocots and dicots, and are even similar to the conserved domains of the animal E2Fs. Such conservation indicates a functional similarity between plant and animal E2Fs. E2F transcription factors that regulate meristem development act through common cis-elements, and regulate related (PCNA) genes. (Kosugi and Ohashi, (2002) Plant J. 29: 45-59).
  • the ABI5 gene (ABA insensitive 5) encodes a basic leucine zipper factor required for ABA response in the seed and vegetative tissues.
  • Co-transfonnation experiments with ABI5 cDNA constructs in rice protoplasts resulted in specific transactivation of the ABA-inducible wheat, Arabidopsis, bean, and barley promoters. These results demonstrate that sequentially similar ABI5 transcription factors are key targets of a conserved ABA signaling pathway in diverse plants. (Gampala et al. (2001) J. Biol. Chem. 277: 1689-1694).
  • Bioactive gibberellins are essential endogenous regulators of plant growth. GA signaling tends to be conserved across the plant kingdom. GA signaling is mediated via GAI, a nuclear member of the GRAS family of plant transcription factors. Arabidopsis GAI has been shown to function in rice to inhibit gibberellin response pathways. (Fu et al. (2001) Plant Cell 13 : 1791- 1802).
  • the Arabidopsis gene SUPERMAN (SUP), encodes a putative transcription factor that maintains the boundary between stamens and carpels.
  • Wheat reduced height- 1 (Rht-Bl/Rht-Dl) and maize dwarf-8 (d8) genes are orthologs of the Arabidopsis gibberellin insensitive (GAI) gene. Both of these genes have been used to produce dwarf grain varieties that have improved grain yield. These genes encode proteins that resemble nuclear transcription factors and contain an SH2-like domain, indicating that phosphotyrosine may participate in gibberellin signaling. Transgenic rice plants containing a mutant GAI allele from Arabidopsis have been shown to produce reduced responses to gibberellin and are dwarfed, indicating that mutant GAI orthologs could be used to increase yield in a wide range of crop species (Peng et al. (1999) Nature 400: 256-261).
  • Transcription factors that are homologous to the listed sequences will typically share at least about 51% and 64% amino acid sequence identity in the Staygreen and B3 domains, respectively. More closely related transcription factors can share at least about 64% and about 75%) amino acid sequence identity in the Staygreen and B3 domains, respectively, or more sequence identity with the listed sequences, or with the listed sequences but excluding or outside a known consensus sequence or consensus DNA-binding site, or with the listed sequences excluding one or all conserved domains.
  • the sequences will typically share at least about 40% nucleotide sequence identity, preferably at least about 50%, about 60%, about 70% or about 80% sequence identity, and more preferably about 85%, about 90%, about 95% or about 97% or more sequence identity to one or more of the listed sequences, or to a listed sequence but excluding or outside a known consensus sequence or consensus DNA-binding site, or outside one or all conserved domain.
  • the degeneracy of the genetic code enables major variations in the nucleotide sequence of a polynucleotide while maintaining the amino acid sequence of the encoded protein.
  • B3 domains within the B3 transcription factor family may exhibit a higher degree of sequence homology, such as at least 77% amino acid sequence identity including conservative substitutions, and preferably at least 80% sequence identity, and more preferably at least 85%, or at least about 86%), or at least about 87%, or at least about 88%, or at least about 90%, or at least about 95%, or at least about 98% sequence identity.
  • Transcription factors that are homologous to the listed sequences should share at least 30%, or at least about 60%, or at least about 75%, or at least about 80%), or at least about 90%, or at least about 95%o amino acid sequence identity over the entire length of the polypeptide or the homolog.
  • Percent identity can be determined electronically, e.g., by using the MEGALIGN program (DNASTAR, Inc. Madison, Wis.).
  • the MEGALIGN program can create alignments between two or more sequences according to different methods, for example, the clustal method (for example, Higgins and Sharp (1988) Gene 73 : 237-244).
  • the clustal algorithm groups sequences into clusters by examining the distances between all pairs. The clusters are aligned pairwise and then in groups.
  • Other alignment algorithms or programs may be used, including FASTA, BLAST, or ENTREZ, FASTA and BLAST, and which may be used to calculate percent similarity.
  • the percent identity of two sequences can be determined by the GCG program with a gap weight of 1, e.g., each amino acid gap is weighted as if it were a single amino acid or nucleotide mismatch between the two sequences (for example, USPN 6,262,333).
  • the percentage similarity between two polypeptide sequences is calculated by dividing the length of sequence A, minus the number of gap residues in sequence A, minus the number of gap residues in sequence B, into the sum of the residue matches between sequence A and sequence B, times one hundred. Gaps of low or of no similarity between the two amino acid sequences are not included in determining percentage similarity. Percent identity between polynucleotide sequences can also be counted or calculated by other methods known in the art, e.g., the Jotun Hein method (for example, Hein (1990) Methods Enzymol. 183 : 626-645). Identity between sequences can also be determined by other methods known in the art, e.g., by varying hybridization conditions (U.S. Patent Application No. 2001/0010913).
  • an alignment program that permits gaps in the sequence is used to align the sequences.
  • the Smith-Waterman is one type of algorithm that permits gaps in sequence alignments (Shpaer (1997) Methods Mol. Biol. 70: 173-187).
  • the GAP program using the Needleman and Wunsch alignment method can be utilized to align sequences.
  • An alternative search strategy uses MPSRCH software, which runs on a MASPAR computer.
  • MPSRCH uses a Smith-Waterman algorithm to score sequences on a massively parallel computer. This approach improves ability to pick up distantly related matches, and is especially tolerant of small gaps and nucleotide sequence errors.
  • Nucleic acid-encoded amino acid sequences can be used to search both protein and DNA databases.
  • the invention provides methods for identifying a sequence similar or paralogous or orthologous or homologous to one or more polynucleotides as noted herein, or one or more target polypeptides encoded by the polynucleotides, or otherwise noted herein and may include linking or associating a given plant phenotype or gene function with a sequence.
  • a sequence database is provided (locally or across an internet or intranet) and a query is made against the sequence database using the relevant sequences herein and associated plant phenotypes or gene functions.
  • polynucleotide sequences or one or more polypeptides encoded by the polynucleotide sequences may be used to search against a BLOCKS (Bairoch et al. (1997) Nucleic Acids Res. 25: 217-221), PFAM, and other databases which contain previously identified and annotated motifs, sequences and gene functions.
  • Methods that search for primary sequence patterns with secondary structure gap penalties Smith et al. (1992) Protein Engineering 5: 35-51) as well as algorithms such as Basic Local Alignment Search Tool (BLAST; Altschul (1993) J. Mol. Evol. 36: 290-300; Altschul et al. (1990) J. Mol. Biol.
  • a further method for identifying or confirming that specific homologous sequences control the same function is by comparison of the transcript profile(s) obtained upon overexpression or knockout of two or more related transcription factors. Since transcript profiles are diagnostic for specific cellular states, one skilled in the art will appreciate that genes that have a highly similar transcript profile (e.g., with greater than 50% regulated transcripts in common, more preferably with greater than 70% regulated transcripts in common, most preferably with greater than 90% regulated transcripts in common) will have highly similar functions. Fowler et al.
  • methods using manual alignment of sequences similar or homologous to one or more polynucleotide sequences or one or more polypeptides encoded by the polynucleotide sequences may be used to identify regions of similarity and B3 binding or staygreen domains.
  • Such manual methods are well known of those of skill in the art and can include, for example, comparisons of tertiary structure between a polypeptide sequence encoded by a polynucleotide that comprises a known function, with a polypeptide sequence encoded by a polynucleotide sequence which has a function not yet determined.
  • Such examples of tertiary structure may comprise predicted a-helices, ⁇ -sheets, amphipathic helices, leucine zipper motifs, zinc finger motifs, proline-rich regions, cysteine repeat motifs, and the like.
  • Orthologs and paralogs of presently disclosed transcription factors may be cloned using compositions provided by the present invention according to methods well known in the art.
  • cDNAs can be cloned using mRNA from a plant cell or tissue that expresses one of the present transcription factors.
  • Appropriate mRNA sources may be identified by interrogating Northern blots with probes designed from the present transcription factor sequences, after which a library is prepared from the mRNA obtained from a positive cell or tissue.
  • Transcription factor- encoding cDNA is then isolated using an amplification method, for example, PCR, with primers designed from a presently disclosed transcription factor gene sequence, or by probing with a partial or complete cDNA or with one or more sets of degenerate probes based on the disclosed sequences.
  • the cDNA library may be used to transform plant cells. Expression of the cDNAs of interest is detected using, for example, methods disclosed herein such as microarrays,
  • Polynucleotides homologous to the sequences illustrated in the Sequence Listing can be identified, e.g., by hybridization to each other under stringent conditions.
  • Single-stranded polynucleotides hybridize when they associate based on a variety of well characterized physical- chemical forces, such as hydrogen bonding, solvent exclusion, base stacking and the like.
  • the stringency of a hybridization reflects the degree of sequence identity of the nucleic acids involved, such that the higher the stringency, the more similar are the two polynucleotide strands.
  • Stringency is influenced by a variety of factors, including temperature, salt concentration and composition, organic and non-organic additives, solvents, etc., present in both the hybridization and wash solutions and incubations (and number thereof), as described in more detail in the references cited above.
  • polynucleotide sequences that are capable of hybridizing to the claimed polynucleotide sequences, including any of the transcription factor polynucleotides within the Sequence Listing, and fragments thereof under various conditions of stringency (for example, Wahl and Berger (1987) Methods Enzymol. 152: 399-407; and Kimmel (1987) Methods Enzymol. 152: 507-51 1).
  • full- length cDNA, orthologs, and paralogs of the present nucleotide sequences may be identified and isolated using well-known methods.
  • the cDNA libraries, orthologs, and paralogs of the present nucleotide sequences may be screened using hybridization methods to determine their utility as hybridization target or amplification probes.
  • T m The melting temperature
  • T m (°C) 79.8+18.5(log[Na+])+0.58(%G+Q+0.12(%G+C) 2 -0.35(% formamide) - 820/L
  • L is the length of the duplex formed
  • [Na+] is the molar concentration of the sodium ion in the hybridization or washing solution
  • % G+C is the percentage of (guanine+cytosine) bases in the hybrid.
  • approximately 1° C is required to reduce the melting temperature for each 1% mismatch.
  • Hybridization experiments are generally conducted in a buffer of pH between 6.8 to 7.4, although the rate of hybridization is nearly independent of pH at ionic strengths likely to be used in the hybridization buffer (Anderson and Young (1985) supra).
  • one or more of the following may be used to reduce non-specific hybridization: sonicated salmon sperm DNA or another non-complementary DNA, bovine serum albumin, sodium pyrophosphate, sodium dodecyl sulfate (SDS), polyvinylpyrrolidone, ficoll and Denhardt's solution.
  • Dextran sulfate and polyethylene glycol 6000 act to exclude DNA from solution, thus raising the effective probe DNA concentration and the hybridization signal within a given unit of time.
  • conditions of even greater stringency may be desirable or required to reduce non-specific and/or background hybridization. These conditions may be created with the use of higher temperature, lower ionic strength and higher concentration of a denaturing agent such as formamide.
  • Stringency conditions can be adjusted to screen for moderately similar fragments such as homologous sequences from distantly-related organisms, or to highly similar fragments such as genes that duplicate functional enzymes from closely-related organisms.
  • the stringency can be adjusted either during the hybridization step or in the post-hybridization washes.
  • Salt concentration, formamide concentration, hybridization temperature and probe lengths are variables that can be used to alter stringency (as described by the formula above).
  • high stringency is typically performed at T m -5° C to T m -20° C
  • moderate stringency at T m -20° C to T m -35° C and low stringency at T m -35° C to T m -50° C for duplex >150 base pairs.
  • Hybridization may be performed at low to moderate stringency (25-50° C below T m ), followed by post-hybridization washes at increasing stringencies.
  • Maximum rates of hybridization in solution are determined empirically to occur at T m -25° C for DNA-DNA duplex and T m -15° C for RNA-DNA duplex.
  • the degree of dissociation may be assessed after each wash step to determine the need for subsequent, higher stringency wash steps.
  • High stringency conditions may be used to select for nucleic acid sequences with high degrees of identity to the disclosed sequences.
  • An example of stringent hybridization conditions obtained in a filter-based method such as a Southern or northern blot for hybridization of complementary nucleic acids that have more than 100 complementary residues is about 5°C to 20°C lower than the thermal melting point (T m ) for the specific sequence at a defined ionic strength and pH.
  • Conditions used for hybridization may include about 0.02 M to about 0.15 M sodium chloride, about 0.5% to about 5% casein, about 0.02%> SDS or about 0.1% N-laurylsarcosine, about 0.001 M to about 0.03 M sodium citrate, at hybridization temperatures between about 50° C and about 70° C.
  • high stringency conditions are about 0.02 M sodium chloride, about 0.5% casein, about 0.02% SDS, about 0.001 M sodium citrate, at a temperature of about 50° C.
  • Nucleic acid molecules that hybridize under stringent conditions will typically hybridize to a probe based on either the entire DNA molecule or selected portions, e.g., to a unique subsequence, of the DNA.
  • Stringent salt concentration will ordinarily be less than about 750 mM NaCl and 75 mM trisodium citrate. Increasingly stringent conditions may be obtained with less than about 500 mM NaCl and 50 mM trisodium citrate, to even greater stringency with less than about 250 mM
  • Low stringency hybridization can be obtained in the absence of organic solvent, e.g., formamide, whereas high stringency hybridization may be obtained in the presence of at least about 35% formamide, and more preferably at least about 50% formamide.
  • Stringent temperature conditions will ordinarily include temperatures of at least about 30° C, more preferably of at least about 37° C, and most preferably of at least about 42° C with formamide present. Varying additional parameters, such as hybridization time, the concentration of detergent, e.g., sodium dodecyl sulfate (SDS) and ionic strength, are well known to those skilled in the art. Various levels of stringency are accomplished by combining these various conditions as needed.
  • SDS sodium dodecyl sulfate
  • washing steps that follow hybridization may also vary in stringency; the post-hybridization wash steps primarily determine hybridization specificity, with the most critical factors being temperature and the ionic strength of the final wash solution. Wash stringency can be increased by decreasing salt concentration or by increasing temperature. Stringent salt concentration for the wash steps will preferably be less than about 30 mM NaCl and 3 mM trisodium citrate, and most preferably less than about 15 mM NaCl and 1.5 mM trisodium citrate.
  • hybridization and wash conditions that may be used to bind and remove polynucleotides with less than the desired homology to the nucleic acid sequences or their complements that encode the present transcription factors include, for example: 6X SSC at 65° C; 50% formamide, 4X SSC at 42° C; or 0.5X SSC, 0.1% SDS at 65° C; with, for example, two wash steps of 10 - 30 minutes each. Useful variations on these conditions will be readily apparent to those skilled in the art.
  • wash steps of even greater stringency, including about 0.2X SSC, 0.1%) SDS at 65° C and washing twice, each wash step being about 30 min, or about 0.1 X SSC, 0.1%) SDS at 65° C and washing twice for 30 min.
  • the temperature for the wash solutions will ordinarily be at least about 25° C, and for greater stringency at least about 42° C.
  • Hybridization stringency may be increased further by using the same conditions as in the hybridization steps, with the wash temperature raised about 3° C to about 5° C, and stringency may be increased even further by using the same conditions except the wash temperature is raised about 6° C to about 9° C.
  • wash steps may be performed at a lower temperature, e.g., 50° C.
  • An example of a low stringency wash step employs a solution and conditions of at least 25° C in 30 mM NaCl, 3 mM trisodium citrate, and 0.1%> SDS over 30 min. Greater stringency may be obtained at 42° C in 15 mM NaCl, with 1.5 mM trisodium citrate, and 0.1% SDS over 30 min. Even higher stringency wash conditions are obtained at 65° C -68° C in a solution of 15 mM NaCl, 1.5 mM trisodium citrate, and 0.1%> SDS. Wash procedures will generally employ at least two final wash steps. Additional variations on these conditions will be readily apparent to those skilled in the art (for example, U.S. Patent Application No. 20010010913).
  • Stringency conditions can be selected such that an oligonucleotide that is perfectly complementary to the coding oligonucleotide hybridizes to the coding oligonucleotide with at least about a 5-10 x higher signal to noise ratio than the ratio for hybridization of the perfectly complementary oligonucleotide to a nucleic acid encoding a transcription factor known as of the filing date of the application. It may be desirable to select conditions for a particular assay such that a higher signal to noise ratio, that is, about 15x or more, is obtained.
  • a subject nucleic acid will hybridize to a unique coding oligonucleotide with at least a 2x or greater signal to noise ratio as compared to hybridization of the coding oligonucleotide to a nucleic acid encoding known polypeptide.
  • the particular signal will depend on the label used in the relevant assay, e.g., a fluorescent label, a colorimetric label, a radioactive label, or the like.
  • Labeled hybridization or PCR probes for detecting related polynucleotide sequences may be produced by oligolabeling, nick translation, end-labeling, or PCR amplification using a labeled nucleotide.
  • Stringency conditions can be adjusted to screen for moderately similar fragments, such as homologous sequences from distantly related organisms, to highly similar fragments, such as genes that duplicate functional enzymes from closely related organisms. Post-hybridization washes determine stringency conditions.
  • transcription factor homolog polypeptides can be obtained by screening an expression library using antibodies specific for one or more transcription factors.
  • the encoded polypeptide(s) can be expressed and purified in a heterologous expression system (e.g., E. coli) and used to raise antibodies (monoclonal or polyclonal) specific for the polypeptide(s) in question.
  • Antibodies can also be raised against synthetic peptides derived from the sequences of transcription factors or homologous sequences. Methods of raising antibodies are well known in the art and are described in Harlow and Lane (1988), Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, New York.
  • Such antibodies can then be used to screen an expression library produced from the plant from which it is desired to clone additional transcription factor homologs, using the methods described above.
  • the selected cDNAs can be confirmed by sequencing and enzymatic activity.
  • any of a variety of polynucleotide sequences are capable of encoding the transcription factors and transcription factor homolog polypeptides of the invention. Due to the degeneracy of the genetic code, many different polynucleotides can encode identical and/or substantially similar polypeptides in addition to those sequences illustrated in the Sequence Listing. Nucleic acids having a sequence that differs from the sequences shown in the Sequence Listing, or complementary sequences, that encode functionally equivalent peptides (i.e., peptides having some degree of equivalent or similar biological activity) but differ in sequence from the sequence shown in the Sequence Listing due to degeneracy in the genetic code, are also within the scope of the invention.
  • Altered polynucleotide sequences encoding polypeptides include sequences with deletions, insertions, or substitutions of different nucleotides, resulting in a polynucleotide encoding a polypeptide with at least one functional characteristic of the instant polypeptides. Included within this definition are polymorphisms which may or may not be readily detectable using a particular oligonucleotide probe of the polynucleotide encoding the instant polypeptides, and improper or unexpected hybridization to allelic variants, with a locus other than the normal chromosomal locus for the polynucleotide sequence encoding the instant polypeptides.
  • Allelic variant refers to any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variation arises naturally through mutation, and may result in phenotypic polymorphism within populations. Gene mutations can be silent (i.e., no change in the encoded polypeptide) or may encode polypeptides having altered amino acid sequence.
  • allelic variant is also used herein to denote a protein encoded by an allelic variant of a gene.
  • Splice variant refers to alternative forms of RNA transcribed from a gene.
  • Splice variation arises naturally through use of alternative splicing sites within a transcribed RNA molecule, or less commonly between separately transcribed RNA molecules, and may result in several mRNAs transcribed from the same gene.
  • Splice variants may encode polypeptides having altered amino acid sequence.
  • the term splice variant is also used herein to denote a protein encoded by a splice variant of an mRNA transcribed from a gene.
  • ABB (Arabidopsis - SEQ ID NO: 2; canola - SEQ ID NO: 8), represents a single transcription factor; allelic variation and alternative splicing may be expected to occur.
  • Allelic variants of SEQ ID NO: 2 or SEQ ID NO: 8 can be cloned by probing cDNA or genomic libraries from different individual organisms according to standard procedures. Allelic variants of the DNA sequence shown in SEQ ID NO: 2 or SEQ ID NO: 8, including those containing silent mutations and those in which mutations result in amino acid sequence changes, are within the scope of the present invention, as are proteins which are allelic variants of SEQ ID NO: 1 or SEQ ID NO: 7.
  • cDNAs generated from alternatively spliced mRNAs, which retain the properties of the transcription factor are included within the scope of the present invention, as are polypeptides encoded by such cDNAs and mRNAs.
  • Allelic variants and splice variants of these sequences can be cloned by probing cDNA or genomic libraries from different individual organisms or tissues according to standard procedures known in the art (for example, U.S. Patent No. 6,388,064).
  • the invention also encompasses related nucleic acid molecules that include allelic or splice variants of SEQ ID NO: 2, 4, 6, and 8, and include sequences which are complementary to any of the above nucleotide sequences.
  • Related nucleic acid molecules also include nucleotide sequences encoding a polypeptide comprising a substitution, modification, addition and/or deletion of one or more amino acid residues compared to the polypeptides as set forth in any of SEQ ID NO: 1, 3, 5 and 7.
  • Such related polypeptides may comprise, for example, additions and/or deletions of one or more N-linked or O-linked glycosylation sites, or an addition and/or a deletion of one or more cysteine residues.
  • Table 2 illustrates, e.g., that the codons AGC, AGT, TCA, TCC, TCG, and TCT all encode the same amino acid: serine. Accordingly, at each position in the sequence where there is a codon encoding serine, any of the above trinucleotide sequences can be used without altering the encoded polypeptide.
  • Lysine (Lys, K) AAA AAG Leucine (Leu, L) TTA TTG CTA CTC CTG CTT
  • Serine (Ser, S) AGC AGT TCA TCC TCG TCT
  • conservative variations that alter one, or a few amino acid residues in the encoded polypeptide, can be made without altering the function of the polypeptide, these conservative variants are, likewise, a feature of the invention.
  • substitutions, deletions and insertions introduced into the sequences provided in the Sequence Listing are also envisioned by the invention.
  • Such sequence modifications can be engineered into a sequence by site-directed mutagenesis (Wu (ed.) Methods Enzymol. (1993) vol. 217, Academic Press) or the other methods noted below.
  • Amino acid substitutions are typically of single residues; insertions usually will be on the order of about from 1 to 10 amino acid residues; and deletions will range about from 1 to 30 residues.
  • deletions or insertions are made in adjacent pairs, e.g., a deletion of two residues or insertion of two residues. Substitutions, deletions, insertions or any combination thereof can be combined to arrive at a sequence.
  • the mutations that are made in the polynucleotide encoding the transcription factor should not place the sequence out of reading frame and should not create complementary regions that could produce secondary mRNA structure.
  • the polypeptide encoded by the DNA performs the desired function.
  • Conservative substitutions are those in which at least one residue in the amino acid sequence has been removed and a different residue inserted in its place. Such substitutions generally are made in accordance with the Table 3 when it is desired to maintain the activity of the protein. Table 3 shows amino acids which can be substituted for an amino acid in a protein and which are typically regarded as conservative substitutions.
  • substitutions are those in which at least one residue in the amino acid sequence has been removed and a different residue inserted in its place. Such substitutions generally are made in accordance with the Table 4 when it is desired to maintain the activity of the protein.
  • Table 4 shows amino acids which can be substituted for an amino acid in a protein and which are typically regarded as structural and functional substitutions. For example, a residue in column 1 of Table 4 may be substituted with a residue in column 2; in addition, a residue in column 2 of Table 4 may be substituted with the residue of column 1.
  • Substitutions that are less conservative than those in Table 4 can be selected by picking residues that differ more significantly in their effect on maintaining (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a sheet or helical conformation, (b) the charge or hydrophobicity of the molecule at the target site, or (c) the bulk of the side chain.
  • substitutions which in general are expected to produce the greatest changes in protein properties will be those in which (a) a hydrophilic residue, e.g., seryl or threonyl, is substituted for (or by) a hydrophobic residue, e.g., leucyl, isoleucyl, phenylalanyl, valyl or alanyl; (b) a cysteine or proline is substituted for (or by) any other residue; (c) a residue having an electropositive side chain, e.g., lysyl, arginyl, or histidyl, is substituted for (or by) an electronegative residue, e.g., glutamyl or aspartyl; or (d) a residue having a bulky side chain, e.g., phenylalanine, is substituted for (or by) one not having a side chain, e.g., glycine.
  • a hydrophilic residue e.g
  • the present invention optionally includes methods of modifying the sequences of the Sequence Listing.
  • nucleic acid or protein modification methods are used to alter the given sequences to produce new sequences and/or to chemically or enzymatically modify given sequences to change the properties of the nucleic acids or proteins.
  • nucleic acid sequences can be modified, e.g., according to standard mutagenesis or artificial evolution methods to produce modified sequences.
  • the modified sequences may be created using purified natural polynucleotides isolated from any organism or may be synthesized from purified compositions and chemicals using chemical means well known to those of skill in the art.
  • Ausubel, supra provides additional details on mutagenesis methods.
  • Artificial forced evolution methods are described, for example, by Stemmer (1994) Nature 370: 389-391, Stemmer (1994) Proc. Natl. Acad. Sci. 91 : 10747-10751, and US Patents 5,811,238, 5,837,500, and 6,242,568.
  • sequence can be modified by addition of lipids, sugars, peptides, organic or inorganic compounds, by the inclusion of modified nucleotides or amino acids, or the like.
  • protein modification techniques are illustrated in Ausubel, supra. Further details on chemical and enzymatic modifications can be found herein. These modification methods can be used to modify any given sequence, or to modify any sequence produced by the various mutation and artificial evolution modification methods noted herein.
  • the invention provides for modification of any given nucleic acid by mutation, evolution, chemical or enzymatic modification, or other available methods, as well as for the products produced by practicing such methods, e.g., using the sequences herein as a starting substrate for the various modification approaches.
  • optimized coding sequence containing codons preferred by a particular prokaryotic or eukaryotic host can be used e.g., to increase the rate of translation or to produce recombinant RNA transcripts having desirable properties, such as a longer half-life, as compared with transcripts produced using a non-optimized sequence.
  • Translation stop codons can also be modified to reflect host preference. For example, preferred stop codons for Saccharomyces cerevisiae and mammals are TAA and TGA, respectively. The preferred stop codon for monocotyledonous plants is TGA, whereas insects and E. coli prefer to use TAA as the stop codon.
  • polynucleotide sequences of the present invention can also be engineered in order to alter a coding sequence for a variety of reasons, including but not limited to, alterations which modify the sequence to facilitate cloning, processing and/or expression of the gene product.
  • alterations are optionally introduced using techniques which are well known in the art, e.g., site-directed mutagenesis, to insert new restriction sites, to alter glycosylation patterns, to change codon preference, to introduce splice sites, etc.
  • a fragment or domain derived from any of the polypeptides of the invention can be combined with domains derived from other transcription factors or synthetic domains to modify the biological activity of a transcription factor.
  • a DNA-binding domain derived from a transcription factor of the invention can be combined with the activation domain of another transcription factor or with a synthetic activation domain.
  • a transcription activation domain assists in initiating transcription from a DNA-binding site. Examples include the transcription activation region of VP16 or GAL4 (Moore et al. (1998) Proc. Natl. Acad. Sci. 95: 376-381; Aoyama et al.
  • polynucleotide sequences of the invention are incorporated into recombinant DNA (or RNA) molecules that direct expression of polypeptides of the invention in appropriate host cells, transgenic plants, in vitro translation systems, or the like. Due to the inherent degeneracy of the genetic code, nucleic acid sequences which encode substantially the same or a functionally equivalent amino acid sequence can be substituted for any listed sequence to provide for cloning and expressing the relevant homolog.
  • transgenic plants of the present invention comprising recombinant polynucleotide sequences are generally derived from parental plants, which may themselves be non-transformed (or non- transgenic) plants. These transgenic plants may either have a transcription factor gene "knocked out” (for example, with a genomic insertion by homologous recombination, an antisense or ribozyme construct) or expressed to a normal or wild-type extent. However, overexpressing transgenic "progeny" plants will exhibit greater mRNA levels, wherein the mRNA encodes a transcription factor, that is, a DNA-binding protein that is capable of binding to a DNA regulatory sequence and inducing transcription, and preferably, expression of a plant trait gene.
  • a transcription factor that is, a DNA-binding protein that is capable of binding to a DNA regulatory sequence and inducing transcription, and preferably, expression of a plant trait gene.
  • the mRNA expression level will be at least three-fold greater than that of the parental plant, or more preferably at least ten-fold greater mRNA levels compared to said parental plant, and most preferably at least fifty-fold greater compared to said parental plant.
  • the present invention includes recombinant constructs comprising one or more of the nucleic acid sequences herein.
  • the constructs typically comprise a vector, such as a plasmid, a cosmid, a phage, a virus (e.g., a plant virus), a bacterial artificial chromosome (BAC), a yeast artificial chromosome (YAC), or the like, into which a nucleic acid sequence of the invention has been inserted, in a forward or reverse orientation.
  • the construct further comprises regulatory sequences, including, for example, a promoter, operably linked to the sequence. Large numbers of suitable vectors and promoters are known to those of skill in the art, and are commercially available.
  • non-Ti vectors can be used to transfer the DNA into monocotyledonous plants and cells by using free DNA delivery techniques.
  • free DNA delivery techniques can involve, for example, the use of liposomes, electroporation, microprojectile bombardment, silicon carbide whiskers, and viruses.
  • transgenic plants such as wheat, rice (Christou (1991) Bio/Technology 9: 957-962) and corn (Gordon-Kamm (1990) Plant Cell 2: 603-618) can be produced.
  • An immature embryo can also be a good target tissue for monocots for direct DNA delivery techniques by using the particle gun (Weeks et al. (1993) Plant Physiol.
  • plant transformation vectors include one or more cloned plant coding sequence (genomic or cDNA) under the transcriptional control of 5' and 3' regulatory sequences and a dominant selectable marker.
  • Such plant transformation vectors typically also contain a promoter (e.g., a regulatory region controlling inducible or constitutive, environmentally-or developmentally-regulated, or cell- or tissue-specific expression), a transcription initiation start site, an RNA processing signal (such as intron splice sites), a transcription termination site, and/or a polyadenylation signal.
  • a promoter e.g., a regulatory region controlling inducible or constitutive, environmentally-or developmentally-regulated, or cell- or tissue-specific expression
  • RNA processing signal such as intron splice sites
  • a potential utility for the transcription factor polynucleotides disclosed herein is the isolation of promoter elements from these genes that can be used to program expression in plants of any genes.
  • Each transcription factor gene disclosed herein is expressed in a unique fashion, as determined by promoter elements located upstream of the start of translation, and additionally within an intron of the transcription factor gene or downstream of the termination codon of the gene.
  • the promoter sequences are located entirely in the region directly upstream of the start of translation. In such cases, typically the promoter sequences are located within 2.0 kb of the start of translation, or within 1.5 kb of the start of translation, frequently within 1.0 kb of the start of translation, and sometimes within 0.5 kb of the start of translation.
  • the promoter sequences can be isolated according to methods known to one skilled in the art.
  • constitutive plant promoters which can be useful for expressing the TF sequence include: the cauliflower mosaic virus (CaMV) 35S promoter, which confers constitutive, high- level expression in most plant tissues (for example, Odell et al. (1985) Nature 313 : 810-812); the nopaline synthase promoter (An et al. (1988) Plant Physiol. 88: 547-552); and the octopine synthase promoter (Fromm et al. (1989) Plant Cell 1 : 977-984).
  • CaMV cauliflower mosaic virus
  • octopine synthase promoter Fromm et al. (1989) Plant Cell 1 : 977-984.
  • the transcription factors of the invention may be operably linked with a specific promoter that causes the transcription factor to be expressed in response to environmental, tissue-specific or temporal signals.
  • a specific promoter that causes the transcription factor to be expressed in response to environmental, tissue-specific or temporal signals.
  • a variety of plant gene promoters that regulate gene expression in response to environmental, hormonal, chemical, developmental signals, and in a tissue-active manner can be used for expression of a TF sequence in plants. Choice of a promoter is based largely on the phenotype of interest and is determined by such factors as tissue (e.g., seed, fruit, root, pollen, vascular tissue, flower, carpel, etc.), inducibility (e.g., in response to drought, wounding, heat, cold, light, pathogens, etc.), timing, developmental stage, and the like.
  • tissue e.g., seed, fruit, root, pollen, vascular tissue, flower, carpel, etc.
  • inducibility e.g., in response to drought, wounding
  • tissue-specific promoters include: seed-specific promoters (such as the napin, phaseolin or DC3 promoter described in U.S. Patent No. 5,773,697), fruit-specific promoters that are active during fruit ripening (such as the drul promoter (U.S. Patent No. 5,783,393), or the 2A11 promoter (U.S. Pat.ent No. 4,943,674) and the tomato polygalacturonase promoter (Bird et al. (1988) Plant Mol. Biol.
  • root-specific promoters such as those disclosed in US Patent Nos. 5,618,988, 5,837,848 and 5,905,186
  • pollen-active promoters such as PTA29, PTA26 and PTA13 (US Pat. No. 5,792,929)
  • promoters active in vascular tissue Rost and Keller (1998) Plant Mol. Biol. 37: 977-988
  • flower-specific Karl et al. (1995) Plant Mol. Biol. 28: 231-243
  • pollen Baerson et al. (1994) Plant Mol. Biol. 26: 1947-1959
  • carpels Ohl et al.
  • Additional promoters are those that elicit expression in response to heat (Ainley et al. (1993) Plant Mol. Biol. 22: 13-23), light (e.g., the pea rbcS-3A promoter, Kuhlemeier et al. (1989) Plant Cell 1 : 471-478, and the maize rbcS promoter, Schaffner and Sheen (1991) Plant Cell 3 : 997-1012); wounding (e.g., wunl, Siebertz et al. (1989) Plant Cell 1 : 961-968); pathogens (such as the PR-1 promoter described in Buchel et al. (1999) Plant Mol. Biol.
  • Plant expression vectors can also include RNA processing signals that can be positioned within, upstream or downstream of the coding sequence.
  • the expression vectors can include additional regulatory sequences from the 3 '-untranslated region of plant genes, e.g., a 3' terminator region to increase mRNA stability of the mRNA, such as the PI-II terminator region of potato or the octopine or nopaline synthase 3' terminator regions.
  • Specific initiation signals can aid in efficient translation of coding sequences. These signals can include, e.g., the ATG initiation codon and adjacent sequences. In cases where a coding sequence, its initiation codon, and upstream sequences are inserted into the appropriate expression vector, no additional translational control signals may be needed. However, in cases where only coding sequence (e.g., a mature protein coding sequence) or a portion thereof is inserted, exogenous transcriptional control signals including the ATG initiation codon can be separately provided. The initiation codon is provided in the correct reading frame to facilitate transcription. Exogenous transcriptional elements and initiation codons can be of various origins, both natural and synthetic. The efficiency of expression can be enhanced by the inclusion of enhancers appropriate to the cell system in use.
  • the present invention also relates to host cells which are transduced with vectors of the invention, and the production of polypeptides of the invention (including fragments thereof) by recombinant techniques.
  • Host cells are genetically engineered (i.e., nucleic acids are introduced, e.g., transduced, transformed or transfected) with the vectors of this invention, which may be, for example, a cloning vector or an expression vector comprising the relevant nucleic acids herein.
  • the vector is optionally a plasmid, a viral particle, a phage, a naked nucleic acid, etc.
  • the engineered host cells can be cultured in conventional nutrient media modified as appropriate for activating promoters, selecting transformants, or amplifying the relevant gene.
  • the culture conditions such as temperature, pH and the like, are those previously used with the host cell selected for expression, and will be apparent to those skilled in the art and in the references cited herein, including, Sambrook, supra and Ausubel, supra
  • the host cell can be a eukaryotic cell, such as a yeast cell, or a plant cell, or the host cell can be a prokaryotic cell, such as a bacterial cell.
  • Plant protoplasts are also suitable for some applications.
  • the DNA fragments are introduced into plant tissues, cultured plant cells or plant protoplasts by standard methods including electroporation (Fromm et al. (1985) Proc. Natl. Acad. Sci. 82: 5824-5828), infection by viral vectors such as cauliflower mosaic virus (CaMV) (Hohn et al. (1982) Molecular Biology of Plant Tumors Academic Press, New York, NY, pp.
  • electroporation fromm et al. (1985) Proc. Natl. Acad. Sci. 82: 5824-5828
  • viral vectors such as cauliflower mosaic virus (CaMV) (Hohn et al. (1982) Molecular Biology of Plant Tumors Academic Press, New York, NY, pp.
  • the cell can include a nucleic acid of the invention that encodes a polypeptide, wherein the cell expresses a polypeptide of the invention.
  • the cell can also include vector sequences, or the like.
  • cells and transgenic plants that include any polypeptide or nucleic acid above or throughout this specification, e.g., produced by transduction of a vector of the invention, are an additional feature of the invention.
  • Host cells transformed with a nucleotide sequence encoding a polypeptide of the invention are optionally cultured under conditions suitable for the expression and recovery of the encoded protein from cell culture.
  • the protein or fragment thereof produced by a recombinant cell may be secreted, membrane-bound, or contained intracellularly, depending on the sequence and/or the vector used.
  • expression vectors containing polynucleotides encoding mature proteins of the invention can be designed with signal sequences that direct secretion of the mature polypeptides through a prokaryotic or eukaryotic cell membrane.
  • Polypeptides of the invention may contain one or more modified amino acid residues.
  • the presence of modified amino acids may be advantageous in, for example, increasing polypeptide half-life, reducing polypeptide antigenicity or toxicity, increasing polypeptide storage stability, or the like.
  • Amino acid residue(s) are modified, for example, co-translationally or post- translationally during recombinant production or modified by synthetic or chemical means.
  • Non-limiting examples of a modified amino acid residue include incorporation or other use of acetylated amino acids, glycosylated amino acids, sulfated amino acids, prenylated (e.g., farnesylated, geranylgeranylated) amino acids, PEG modified (e.g., "PEGylated”) amino acids, biotinylated amino acids, carboxylated amino acids, phosphorylated amino acids, etc.
  • PEG modified e.g., "PEGylated” amino acids
  • biotinylated amino acids carboxylated amino acids
  • phosphorylated amino acids etc.
  • the modified amino acid residues may prevent or increase affinity of the polypeptide for another molecule, including, but not limited to, polynucleotides, proteins, carbohydrates, lipids and lipid derivatives, and other organic or synthetic compounds.
  • a transcription factor provided by the present invention can also be used to identify additional endogenous or exogenous molecules that can affect a phenotype or trait of interest.
  • Such molecules include endogenous molecules that are acted upon either at a transcriptional level by a transcription factor of the invention to modify a phenotype as desired.
  • the transcription factors can be employed to identify one or more downstream genes that are subject to a regulatory effect of the transcription factor.
  • a transcription factor or transcription factor homolog of the invention is expressed in a host cell, e.g., a transgenic plant cell, tissue or explant, and expression products, either RNA or protein, of likely or random targets are monitored, e.g., by hybridization to a microarray of nucleic acid probes corresponding to genes expressed in a tissue or cell type of interest, by two-dimensional gel electrophoresis of protein products, or by any other method known in the art for assessing expression of gene products at the level of RNA or protein.
  • a transcription factor of the invention can be used to identify promoter sequences (such as binding sites on DNA sequences) involved in the regulation of a downstream target.
  • interactions between the transcription factor and the promoter sequence can be modified by changing specific nucleotides in the promoter sequence or specific amino acids in the transcription factor that interact with the promoter sequence to alter a plant trait.
  • transcription factor DNA- binding sites are identified by gel shift assays.
  • the promoter region sequences can be employed in double-stranded DNA arrays to identify molecules that affect the interactions of the transcription factors with their promoters (Bulyk et al. (1999) Nature Biotechnol. 17: 573-577).
  • the identified transcription factors are also useful to identify proteins that modify the activity of the transcription factor.
  • Such modification can occur by covalent modification, such as by phosphorylation, or by protein-protein (homo- or heteropolymer) interactions. Any method suitable for detecting protein-protein interactions can be employed. Among the methods that can be employed are co-immunoprecipitation, cross-linking and co-purification through gradients or chromatographic columns, and the two-hybrid yeast system.
  • the two-hybrid system detects protein interactions in vivo and is described in Chien et al. ((1991) Proc. Natl. Acad. Sci. 88: 9578-9582) and is commercially available from Clontech (Palo Alto, Calif).
  • plasmids are constructed that encode two hybrid proteins: one consists of the DNA-binding domain of a transcription activator protein fused to the TF polypeptide and the other consists of the transcription activator protein's activation domain fused to an unknown protein that is encoded by a cDNA that has been recombined into the plasmid as part of a cDNA library.
  • the DNA-binding domain fusion plasmid and the cDNA library are transformed into a strain of the yeast Saccharomyces cerevisiae that contains a reporter gene (e.g., lacZ) whose regulatory region contains the transcription activator's binding site. Either hybrid protein alone cannot activate transcription of the reporter gene. Interaction of the two hybrid proteins reconstitutes the functional activator protein and results in expression of the reporter gene, which is detected by an assay for the reporter gene product. Then, the library plasmids responsible for reporter gene expression are isolated and sequenced to identify the proteins encoded by the library plasmids. After identifying proteins that interact with the transcription factors, assays for compounds that interfere with the TF protein-protein interactions can be performed.
  • a reporter gene e.g., lacZ
  • polynucleotides also referred to herein as oligonucleotides, typically having at least 12 bases, preferably at least 15, more preferably at least 20, 30, or 50 bases, which hybridize under stringent conditions to a polynucleotide sequence described above.
  • the polynucleotides may be used as probes, primers, sense and antisense agents, and the like, according to methods as noted supra.
  • Subsequences of the polynucleotides of the invention are useful as nucleic acid probes and primers.
  • An oligonucleotide suitable for use as a probe or primer is typically at least about 15 nucleotides in length, and frequently at least about 30 or 40 or more nucleotides in length.
  • a nucleic acid probe is useful in hybridization protocols, for example, to identify additional polypeptide homologs of the invention, including protocols for microarray experiments.
  • Primers can be annealed to a complementary target DNA strand by nucleic acid hybridization to form a hybrid between the primer and the target DNA strand, and then extended along the target DNA strand with DNA polymerase. Primer pairs can be used for amplification of a nucleic acid sequence, e.g., by the polymerase chain reaction (PCR) or other nucleic-acid amplification methods (Sambrook, supra, and Ausubel, supra).
  • PCR polymerase chain reaction
  • polypeptides including a subsequence of at least about 15 contiguous amino acids encoded by the recombinant or isolated polynucleotides of the invention.
  • polypeptides, or domains or fragments thereof can be used as immunogens, e.g., to produce antibodies specific for the polypeptide sequence, or as probes for detecting a sequence of interest.
  • a subsequence can range in size from about 15 amino acids in length up to and including the full length of the polypeptide.
  • an expressed polypeptide which comprises such a polypeptide subsequence performs at least one biological function of the intact polypeptide in substantially the same manner, or to a similar extent, as does the intact polypeptide.
  • a polypeptide fragment can comprise a recognizable structural motif or functional domain such as a DNA binding domain that activates transcription, e.g., by binding to a specific DNA promoter region an activation domain, or a domain for protein-protein interactions.
  • the polynucleotides of the invention are favorably employed to produce transgenic plants with various traits, or characteristics, that have been modified in a desirable manner, e.g., to improve the seed characteristics of a plant.
  • alteration of expression levels or patterns e.g., spatial or temporal expression patterns
  • of one or more of the transcription factors (or transcription factor homologs) of the invention as compared with the levels of the same protein found in a wild-type plant, can be used to modify a plant's traits.
  • An illustrative example of trait modification, improved characteristics, by altering expression levels of a particular transcription factor is described further in the Examples and the Sequence Listing.
  • Arabidopsis thaliana is the object of rapidly growing attention as a model for genetics and metabolism in plants. Arabidopsis has a small genome, and well-documented studies are available. It is easy to grow in large numbers and mutants defining important genetically controlled mechanisms are either available, or can readily be obtained. Various methods to introduce and express isolated homologous genes are available (Koncz et al., eds., Methods in Arabidopsis Research (1992) World Scientific, New Jersey, NJ, in "Preface”).
  • Arabidopsis is also a choice organism for the isolation of mutants and studies in morphogenetic and development pathways, and control of these pathways by transcription factors (Koncz (1992) supra, p. 72).
  • a number of studies introducing transcription factors into A. thaliana have demonstrated the utility of this plant for understanding the mechanisms of gene regulation and trait alteration in plants (for example, Koncz (1992) supra, and U.S. Patent No. 6,417,428).
  • transgenic plants comprising isolated polynucleotides encoding transcription factors may also modify expression of endogenous genes, polynucleotides, and proteins.
  • Examples include Peng et al. (1997) Genes and Development 11 : 3194-3205, and Peng et al. (1999) Nature 400: 256-261.
  • Peng et al. 1997) Genes and Development 11 : 3194-3205
  • an Arabidopsis transcription factor expressed in an exogenous plant species elicits the same or very similar phenotypic response (for example, Fu et al. (2001) Plant Cell 13 : 1791-1802; Nandi et al. (2000) Curr. Biol. 10: 215-218; Coupland (1995) Nature 311 : 482-483; and Weigel and Nilsson (1995) Nature 377: 482-500).
  • Homologous genes introduced into transgenic plants may be derived from any plant, or from any source whether natural, synthetic, semi-synthetic or recombinant, and that share significant sequence identity or similarity to those provided by the present invention, may be introduced into plants, for example, crop plants, to confer desirable or improved traits. Consequently, transgenic plants may be produced that comprise a recombinant expression vector or cassette with a promoter operably linked to one or more sequences homologous to presently disclosed sequences.
  • the promoter may be, for example, a plant or viral promoter.
  • the invention thus provides for methods for preparing transgenic plants, and for modifying plant traits. These methods include introducing into a plant a recombinant expression vector or cassette comprising a functional promoter operably linked to one or more sequences homologous to presently disclosed sequences.
  • one or more transcription factor genes of the present invention may be used to increase or decrease, or improve or prove deleterious to a given trait. For example, knocking out a transcription factor gene that naturally occurs in a plant, or suppressing the gene (with, for example, antisense suppression), may cause decreased tolerance to an abiotic stress relative to non-transformed or wild-type plants. By overexpressing this gene, the plant may experience increased tolerance to the same stress. More than one transcription factor gene may be introduced into a plant, either by transforming the plant with one or more vectors comprising two or more transcription factors, or by selective breeding of plants to yield hybrid crosses that comprise more than one introduced transcription factor. Genes, traits and utilities that affect plant characteristics
  • Plant transcription factors can modulate gene expression, and, in turn, be modulated by the environmental experience of a plant. Significant alterations in a plant's environment invariably result in a change in the plant's transcription factor gene expression pattern. Altered transcription factor expression patterns generally result in phenotypic changes in the plant. Transcription factor gene product(s) in transgenic plants then differ(s) in amounts or proportions from that found in wild-type or non-transformed plants, and those transcription factors likely represent polypeptides that are used to alter the response to the environmental change. By way of example, it is well accepted in the art that analytical methods based on altered expression patterns may be used to screen for phenotypic changes in a plant far more effectively than can be achieved using traditional methods.
  • nucleic acids of the invention are also useful for sense and anti-sense suppression of expression, e.g. to down-regulate expression of a nucleic acid of the invention, e.g. as a further mechanism for modulating plant phenotype. That is, the nucleic acids of the invention, or subsequences or anti-sense sequences thereof, can be used to block expression of naturally occurring homologous nucleic acids.
  • sense and anti-sense technologies are known in the art, e.g. as set forth in Lichtenstein and Nellen (1997) Antisense Technology: A Practical Approach, IRL Press at Oxford University Press, Oxford, U.K.
  • Antisense regulation is also described in Crowley et al. (1985) Cell 43 : 633-641; Rosenberg et al. (1985) Nature 313 : 703-706; Preiss et al. (1985) Nature 313 : 27-32; Melton (1985) Proc. Natl. Acad. Sci. 82: 144- 148; Izant and Weintraub (1985) Science 229: 345-352; and Kim and Wold (1985) Cell 42: 129-138. Additional methods for antisense regulation are known in the art. Antisense regulation has been used to reduce or inhibit expression of plant genes in, for example in European Patent Publication No. 271988.
  • Antisense RNA may be used to reduce gene expression to produce a visible or biochemical phenotypic change in a plant (Smith et al. (1988) Nature, 334: 724-726; Smith et al. (1990) Plant Mol. Biol. 14: 369-379).
  • sense or anti-sense sequences are introduced into a cell, where they are optionally amplified, e.g. by transcription.
  • Such sequences include both simple oligonucleotide sequences and catalytic sequences such as ribozymes.
  • a reduction or elimination of expression i.e., a "knock-out" of a transcription factor or transcription factor homolog polypeptide in a transgenic plant, e.g., to modify a plant trait
  • an antisense construct corresponding to the polypeptide of interest as a cDNA.
  • the transcription factor or homolog cDNA is arranged in reverse orientation (with respect to the coding sequence) relative to the promoter sequence in the expression vector.
  • the introduced sequence need not be the full-length cDNA or gene, and need not be identical to the cDNA or gene found in the plant type to be transformed.
  • the antisense sequence need only be capable of hybridizing to the target gene or RNA of interest.
  • the introduced sequence is of shorter length, a higher degree of homology to the endogenous transcription factor sequence will be needed for effective antisense suppression.
  • antisense sequences of various lengths can be used, preferably, the introduced antisense sequence in the vector will be at least 30 nucleotides in length, and improved antisense suppression will typically be observed as the length of the antisense sequence increases.
  • the length of the antisense sequence in the vector will be greater than 100 nucleotides.
  • RNA molecules that are the reverse complement of mRNA molecules transcribed from the endogenous transcription factor gene in the plant cell results in the production of RNA molecules that are the reverse complement of mRNA molecules transcribed from the endogenous transcription factor gene in the plant cell.
  • RNAi is a post-transcriptional, targeted gene-silencing technique that uses double-stranded RNA (dsRNA) to incite degradation of messenger RNA (mRNA) containing the same sequence as the dsRNA (Constans (2002) The Engineer 16: 36).
  • dsRNA double-stranded RNA
  • mRNA messenger RNA
  • siRNAs Small interfering RNAs, or siRNAs are produced in at least two steps: an endogenous ribonuclease cleaves longer dsRNA into shorter, 21-23 nucleoti de-long RNAs. The siRNA segments then mediate the degradation of the target mRNA (Zamore (2001) Nature Struct. Biol. 8: 7 46-750).
  • RNAi has been used for gene function determination in a manner similar to antisense oligonucleotides (Constans (2002) supra).
  • Expression vectors that continually express siRNAs in transiently and stably transfected cells have been engineered to express small hairpin RNAs (shRNAs), which get processed in vivo into siRNAs-like molecules capable of carrying out gene-specific silencing (Brummelkamp et al. (2002) Science 296: 550-553, and Paddison et al. (2002) Genes & Dev. 16: 948-958).
  • shRNAs small hairpin RNAs
  • Post-transcriptional gene silencing by double-stranded RNA is discussed in further detail by Hammond et al.
  • RNA encoded by a transcription factor or transcription factor homolog cDNA can also be used to obtain co- suppression of a corresponding endogenous gene, e.g., in the manner described in U.S. Patent No. 5,231,020 by Jorgensen.
  • Such co-suppression also termed sense suppression
  • the suppressive efficiency will be enhanced as specificity of hybridization is increased, e.g., as the introduced sequence is lengthened, and/or as the sequence similarity between the introduced sequence and the endogenous transcription factor gene is increased.
  • Vectors expressing an untranslatable form of the transcription factor mRNA can also be used to suppress expression of an endogenous transcription factor, thereby reducing or eliminating its activity and modifying one or more traits.
  • Methods for producing such constructs are described in U.S. Patent No. 5,583,021.
  • such constructs are made by introducing a premature stop codon into the transcription factor gene.
  • a plant trait can be modified by gene silencing using double-stranded RNA (Sharp (1999) Genes and Development 13 : 139-141).
  • Another method for abolishing the expression of a gene is by insertion mutagenesis using the T-DNA Agrobacterium tumefaciens. After generating the insertion mutants, the mutants can be screened to identify those containing the insertion in a transcription factor or transcription factor homolog gene. Plants containing a single transgene insertion event at the desired gene can be crossed to generate homozygous plants for the mutation.
  • Such methods are well known to those of skill in the art (for example, Koncz et al. (1992) Methods in Arabidopsis Research, World Scientific Publishing Co. Pte.
  • a plant phenotype can be altered by eliminating an endogenous gene, such as a transcription factor or transcription factor homolog, e.g., by homologous recombination (Kempin et al. (1997) Nature 389: 802-803).
  • a plant trait can also be modified by using the Cre-lox system (for example, as described in U.S. Patent No. 5,658,772).
  • a plant genome can be modified to include first and second lox sites that are then contacted with a Cre recombinase. If the lox sites are in the same orientation, the intervening DNA sequence between the two sites is excised. If the lox sites are in the opposite orientation, the intervening sequence is inverted.
  • polynucleotides and polypeptides of this invention can also be expressed in a plant in the absence of an expression cassette by manipulating the activity or expression level of the endogenous gene by other means, such as, for example, by ectopically expressing a gene by T- DNA activation tagging (Ichikawa et al. (1997) Nature 390 698-701; Kakimoto et al. (1996) Science 274: 982-985).
  • This method entails transforming a plant with a gene tag containing multiple transcriptional enhancers and once the tag has inserted into the genome, expression of a flanking gene coding sequence becomes deregulated.
  • the transcriptional machinery in a plant can be modified so as to increase transcription levels of a polynucleotide of the invention (e.g., PCT Publications WO 96/06166 and WO 98/53057 which describe the modification of the DNA-binding specificity of zinc finger proteins by changing particular amino acids in the DNA-binding motif).
  • the transgenic plant can also include the machinery necessary for expressing or altering the activity of a polypeptide encoded by an endogenous gene, for example, by altering the phosphorylation state of the polypeptide to maintain it in an activated state.
  • Transgenic plants (or plant cells, or plant explants, or plant tissues) incorporating the polynucleotides of the invention and/or expressing the polypeptides of the invention can be produced by a variety of well established techniques as described above.
  • an expression cassette including a polynucleotide, e.g., encoding a transcription factor or transcription factor homolog, of the invention
  • standard techniques can be used to introduce the polynucleotide into a plant, a plant cell, a plant explant or a plant tissue of interest.
  • the plant cell, explant or tissue can be regenerated to produce a transgenic plant.
  • the plant can be any higher plant, including gymnosperms, monocotyledonous and dicotyledonous plants. Suitable protocols are available for Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae (carrot, celery, parsnip), Cruciferae (cabbage, radish, rapeseed, broccoli, etc.), Curcurbitaceae (melons and cucumber), Gramineae (wheat, com, rice, barley, millet, etc.), Solanaceae (potato, tomato, tobacco, peppers, etc.), and various other crops.
  • Leguminosae alfalfa, soybean, clover, etc.
  • Umbelliferae carrot, celery, parsnip
  • Cruciferae cabbage, radish, rapeseed, broccoli, etc.
  • Curcurbitaceae melons and cucumber
  • Gramineae wheat, com, rice, barley, millet, etc
  • Transformation and regeneration of both monocotyledonous and dicotyledonous plant cells is now routine, and the selection of the most appropriate transformation technique will be determined by the practitioner.
  • the choice of method will vary with the type of plant to be transformed; those skilled in the art will recognize the suitability of particular methods for given plant types. Suitable methods can include, but are not limited to: electroporation of plant protoplasts; liposome-mediated transformation; polyethylene glycol (PEG) mediated transformation; transformation using viruses; micro-injection of plant cells; micro-projectile bombardment of plant cells; vacuum infiltration; and Agrobacterium tumefaciens mediated transformation. Transformation means introducing a nucleotide sequence into a plant in a manner to cause stable or transient expression of the sequence.
  • plants are preferably selected using a dominant selectable marker incorporated into the transformation vector.
  • a dominant selectable marker will confer antibiotic or herbicide resistance on the transformed plants, and selection of transformants can be accomplished by exposing the plants to appropriate concentrations of the antibiotic or herbicide.
  • plants showing a modified trait are identified.
  • the modified trait may be environmental stress tolerance.
  • To confirm that the modified trait is due to changes in expression levels or activity of the polypeptide or polynucleotide of the invention can be determined by analyzing mRNA expression using, for example, Northern blots, RT-PCR or microarrays, or protein expression using, for example, immunoblots, Western blots or gel shift assays.
  • the present invention may be an integrated system, computer or computer readable medium that comprises an instruction set for determining the identity of one or more sequences in a database.
  • the instruction set can be used to generate or identify sequences that meet any specified criteria.
  • the instruction set may be used to associate or link certain functional benefits, such improved characteristics, with one or more identified sequence.
  • the instruction set can include, e.g., a sequence comparison or other alignment program, e.g., an available program such as, for example, the Wisconsin Package Version 10.0, such as BLAST, FASTA, PILEUP, FINDPATTERNS or the like (GCG, Madison, WI).
  • a sequence comparison or other alignment program e.g., an available program such as, for example, the Wisconsin Package Version 10.0, such as BLAST, FASTA, PILEUP, FINDPATTERNS or the like (GCG, Madison, WI).
  • GCG Madison, WI
  • Public sequence databases such as GenBank, EMBL, Swiss-Prot and PIR or private sequence databases such as PHYTOSEQ sequence database (Incyte Genomics, Palo Alto, CA) can be searched.
  • sequence comparisons between two (or more) polynucleotides or polypeptides are typically performed by comparing sequences of the two sequences over a comparison window to identify and compare local regions of sequence similarity.
  • the comparison window can be a segment of at least about 20 contiguous positions, usually about 50 to about 200, more usually about 100 to about 150 contiguous positions.
  • a variety of methods for determining sequence relationships can be used, including manual alignment and computer assisted sequence alignment and analysis. This later approach is a preferred approach in the present invention, due to the increased throughput afforded by computer assisted methods. As noted above, a variety of computer programs for performing sequence alignment are available, or can be produced by one of skill.
  • HSPs high scoring sequence pairs
  • T is referred to as the neighborhood word score threshold (Altschul et al. supra). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always > 0) and N (penalty score for mismatching residues; always ⁇ 0). For amino acid sequences, a scoring matrix is used to calculate the cumulative score.
  • Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached.
  • the BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.
  • sequence identity refers to the % sequence identity generated from a tblastx using the NCBI version of the algorithm at the default settings using gapped alignments with the filter "off (for example, NIH NLM NCBI website at ncbi.nlm.nih; world wide web (www) National Institutes of Health US government (gov) website).
  • the BLAST algorithm In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (for example, Karlin and Altschul (1993) Proc. Natl. Acad. Sci. 90: 5873-5787).
  • One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance.
  • a nucleic acid is considered similar to a reference sequence (and, therefore, in this context, homologous) if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.1, or less than about 0.01, and or even less than about 0.001.
  • An additional example of a useful sequence alignment algorithm is PILEUP.
  • PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pairwise alignments. The program can align, e.g., up to 300 sequences of a maximum length of 5,000 letters.
  • the integrated system, or computer typically includes a user input interface allowing a user to selectively view one or more sequence records corresponding to the one or more character strings, as well as an instruction set which aligns the one or more character strings with each other or with an additional character string to identify one or more region of sequence similarity.
  • the system may include a link of one or more character strings with a particular phenotype or gene function.
  • the system includes a user readable output element that displays an alignment produced by the alignment instruction set.
  • the methods of this invention can be implemented in a localized or distributed computing environment.
  • the methods may be implemented on a single computer comprising multiple processors or on a multiplicity of computers.
  • the computers can be linked, e.g. through a common bus, but more preferably the computer(s) are nodes on a network.
  • the network can be a generalized or a dedicated local or wide-area network and, in certain preferred embodiments, the computers may be components of an intranet or an internet.
  • the invention provides methods for identifying a sequence similar or homologous to one or more polynucleotides as noted herein, or one or more target polypeptides encoded by the polynucleotides, or otherwise noted herein and may include linking or associating a given plant phenotype or gene function with a sequence.
  • a sequence database is provided (locally or across an inter or intranet) and a query is made against the sequence database using the relevant sequences herein and associated plant phenotypes or gene functions.
  • Any sequence herein can be entered into the database, before or after querying the database. This provides for both expansion of the database and, if done before the querying step, for insertion of control sequences into the database.
  • the control sequences can be detected by the query to ensure the general integrity of both the database and the query.
  • the query can be performed using a web browser based interface.
  • the database can be a centralized public database such as those noted herein, and the querying can be done from a remote terminal or computer across an internet or intranet.
  • Any sequence herein can be used to identify a similar, homologous, paralogous, or orthologous sequence in another plant. This provides means for identifying endogenous sequences in other plants that may be useful to alter a trait of progeny plants, which results from crossing two plants of different strains. Sequences that encode an ortholog of a sequence herein that naturally occurs in a plant with a desired trait can be identified. The plant is then crossed with a second plant of the same species but which does not have the desired trait to produce progeny which can then be used in further crossing experiments to produce the desired trait in progeny of the second plant.
  • the resulting progeny plants contain no transgenes; expression of the endogenous sequence may also be regulated by treatment with a particular chemical or other means, such as EMR.
  • EMR electrospray chromosomes
  • examples of such well-known compounds include: ethylene; cytokinins; phenolic compounds, which stimulate the transcription of the genes needed for infection; specific monosaccharides and acidic environments which potentiate vir gene induction; acidic polysaccharides which induce one or more chromosomal genes; and opines; other mechanisms include light or dark treatment (an example of a review of examples of such treatments is found in Winans (1992) Microbiol. Rev. 56: 12-31; Eyal et al. (1992) Plant Mol. Biol. 19: 589-599; Chrispeels et al. (2000) Plant Mol. Biol. 42: 279-290; and Piazza et al. (2002) Plant Physiol. 128: 1077-1086).
  • a transcription factor in the region of its conserved domains, such as the Al, B l, B2 and B3 domain (i.e. ABI3), or a Staygreen superfamily (pfam: 12638) domain (i.e. SGR1 and SGR2).
  • Structural analyses may be performed by comparing the structure of the known transcription factor around its conserved domain with those of orthologs and paralogs. Analysis of a number of polypeptides within a transcription factor group or clade, including the functionally or sequentially similar polypeptides provided in the Sequence Listing, may also provide an understanding of structural elements required to regulate transcription within a given family.
  • Plant materials and growth conditions Arabidopsis thaliana ecotype Col-0 was used as the wild type in this study. abi3-6 and abi3-8 mutant lines were isolated from fast neutron- and EMS-mutagenized M2 populations of ecotype Columbia respectively (16). Single T-DNA insertional mutants of SGR1 (At4G22920, SALK_070891, sgrl-1) and SGR2 (AT4G11910, SALK 003830, sgr2-2) were obtained from ABRC and genotyped through PCR to isolate homozygous lines. These lines were crossed and F2 generation was genotyped to isolate the sgrl-llsgr2-2 double mutants. Plant media and growth conditions were done as previously described (28). Siliques were staged for phenotypic analysis of whole embryos and for microarray analysis by tying colored thread around the pedicel on the day of flower opening.
  • Intact siliques were harvested on the indicated number of days after flowering (DAF) and seeds were observed for de-greening or excised with a needle and used for RNA extraction and microarray analysis.
  • Seeds (4 to 5 ml) are placed in sterile 50 ml plastic tubes and 35-40 ml sodium hypochlorite is added to it. The tube is closed and vigorously shaken at room temperature (22- 25 °C) for 20 min. Sodium hypochlorite is discarded and the seeds are rinsed 5 times with 40-45 ml sterile water every 30s. The seeds are decanted into a sterile Petri plate for easy handling.
  • the surface-sterilized seeds (10 to 12) are transferred with forceps onto a Petri plate containing seed germination medium (Mix 0.5 strength of MS major salts (i.e., dissolve 825 mg H 4 NO 3 ,
  • Agrobacterium preparation Agrobacterium is prepared on the same day as seed germination. Streak GV3101 harboring binary vector carrying BnABB under CaMV35S on 2-3 LB plates containing 100 ⁇ g ml "1 rifampicin and 50 ⁇ g ml "1 kanamycin. Incubate the plates for 2 d at 28 °C. A single colony of Agrobacterium from one of the plates is inoculated into 10 ml LB liquid medium containing 100 ⁇ g ml "1 rifampicin and 50 ⁇ g ml "1 kanamycin. The culture is kept for shaking (250 r.p.m) for 36 h at 28 °C.
  • OD is measured at 650 nm using a spectrophotometer. After spinning down the Agrobacterium culture down (4,300-5, 500g) for 10 min at RT, the supernatant is removed and pellet is rinsed in liquid MS minimal organic medium (without antibiotics). The pellet is resuspended in liquid MS minimal organic medium (without antibiotics) and adjusted to 0.05 OD with MS minimal organic medium.
  • the seedlings are pulled out from the seed germination medium and placed in an empty tray.
  • a scalpel blade is used to cut the cotyledons including the 2mm stalk petiole.
  • the cut ends of cotyledon explants i.e, petiole only
  • Agrobacterium (harboring binary vector) suspension OD 0.05
  • the explants are placed onto a cocultivation medium (1 MS major salts, 1 ml MS minor salts, 2.9 ml CaCl 2 stock, 1 ml KI stock, 1 ml vitamin stock and 20 g sucrose; pH 5.8.
  • the explants are transferred into callus induction medium (lx major salts, 1 ml minor salts, 2.9 ml CaCl 2 stock, 1 ml KI stock, 1 ml vitamin stock and 20 g sucrose; pH 5.8.
  • callus induction medium lx major salts, 1 ml minor salts, 2.9 ml CaCl 2 stock, 1 ml KI stock, 1 ml vitamin stock and 20 g sucrose; pH 5.8.
  • the plate is sealed and incubated under dim light at 25 °C for 1 week.
  • the explants are transferred to shoot initiation medium (lx major salts, 1 ml minor salts, 2.9 ml CaCl 2 stock, 1 ml KI stock, 1 ml vitamin stock and 20 g sucrose; pH 5.8. Add 4 g phytagel, autoclave and add filter-sterilized 100 ⁇ AgN0 3 ,
  • the explants with shoot initials are transferred to the shoot outgrowth medium (lx major salts, 1 ml minor salts, 2.9 ml CaCl 2 stock, 1 ml KI stock, 1 ml vitamin stock and 20 g sucrose,40 mg adenine hemisulphate and 500 mg PVP 40,000; pH 5.8.
  • the plates are incubated under light (16 h) at 25 °C for 2-4 weeks.
  • the shoots are transferred using sterile forceps, to tissue culture vessels containing transformant selection medium (lx major salts, 1 ml minor salts, 2.9 ml CaCl 2 stock, 1 ml KI stock, 1 ml vitamin stock, 10 g sucrose, 40 mg adenine hemisulfate and 500 mg PVP 40,000; pH 5.8.
  • transformant selection medium lx major salts, 1 ml minor salts, 2.9 ml CaCl 2 stock, 1 ml KI stock, 1 ml vitamin stock, 10 g sucrose, 40 mg adenine hemisulfate and 500 mg PVP 40,000; pH 5.8.
  • the vessels are incubated in dim light at 25
  • Root initiation The green shoots are transferred to cups containing root initiation medium (0.5x major salts, 0.5 ml minor salts, 1.95 ml CaCl 2 stock, 0.5 ml KI stock and 10 g sucrose; pH 5.8. Add 4 g phytagel, autoclave and add 100 ⁇ filter-sterilized IB A stock solution) with 500 mg liter "1 carbenicillin, using sterile forceps making sure base/ends of the shoots are placed well into the root initiation medium (0.5x major salts, 0.5 ml minor salts, 1.95 ml CaCl 2 stock, 0.5 ml KI stock and 10 g sucrose; pH 5.8. Add 4 g phytagel, autoclave and add 100 ⁇ filter-sterilized IB A stock solution) with 500 mg liter "1 carbenicillin, using sterile forceps making sure base/ends of the shoots are placed well into the
  • the rooted plants are removed from the cup with forceps and washed with lukewarm running tap water to remove traces of phytagel. Fill pots with autoclaved potting mix and water to keep the soil moist. Make a hole in the soil depending on the root length of the regenerated plant and place the plant into the soil with the root going through the hole. Compact the soil and water the plants slightly. Keep the planted pot in a ziplock bag misted with water to maintain humidity. Keep spraying water and maintain humidity till it is ready to be transferred to greenhouse conditions. This may take about a week.
  • Plant transformation for complementation of the abi3-6 mutant A. thaliana AtSGRl, At4g22920, AY850161 and XSGR2, At4gl l910, AY699948 were cloned into the pGEM-T vector (Promega). The excised DNA fragments were cloned into the T-DNA binary vector pCAMter (2X35S: :cDNA). The various constructs carrying SGR1 or SGR2 cDNAs were introduced into tumefaciens GV3101 by electroporation and used for floral dip transformation (29) of abi3-6 mutant plants. Harvested seeds were spread on MS medium containing kanamycin for selection of transgenic plants.
  • RNA from seeds was prepared using RNAqueous columns with the Plant RNA isolation aid (Ambion, Austin, TX, USA) according to manufacturer's instructions. Total RNA samples were quantified using a NanoDrop Spectrophotometer (NanoDrop Technologies). RNA was additionally analyzed by gel electrophoresis to confirm integrity. RT reactions were performed using the Invitrogen Superscript® III Reverse Transcriptase following the manufacturer's directions with 2 ⁇ g total RNA input. qPCRs were performed using a Chromo 4 real-time PCR detector (Bio-Rad) controlled by Opticon Monitor 3 software.
  • Standard curves were generated using five concentrations in triplicate in a dilution series, followed by the test sample run with three biological samples (each analyzed with triplicate technical replicates). qPCR results were quantified by the Pfaffl method as described in the real-time PCR applications guide (Bio-Rad). The Col-0 embryo samples were used as calibrators.
  • the target genes were normalized against the reference ⁇ -tubulin gene (TUB4) or ubiquitin 10 (UBQ10). Reference genes were chosen based on their stable expression across genotypes and treatments. Primers utilized are represented in Table 5.
  • BY-2 cells Biolistic bombardments of cultured tobacco (Nicotiana tabacum) BY-2 cells were performed essentially as described previously (30). The full-length ABB cDNA (At3g24650), ABI3-6 and ABBS cDNAs were cloned into pRTL2 under the control of a CaMV 35S promoter for expression as GFP-tagged proteins. These constructs were bombarded into BY-2 cells. Cells were fixed with 4% paraformaldehyde and visualized directly through fluorescent microscopy for detecting GFP.
  • Microarray analysis Seeds from wild-type Col-0 and abi3-6 were excised from siliques at 13 DAF. Total RNA was extracted and triplicate microarray analysis using independent seed batches was performed. For each sample analyzed, 5 ⁇ g of total RNA was converted to biotin- labeled cRNA using oligo(dT) priming as described by the manufacturer (Enzo kit; Affymetrix) and hybridized to 22K ATH1 Affymetrix microarray s at the Affymetrix Genechip facility (University of Toronto).
  • Microarray data were statistically analyzed with the flexible user friendly graphical interface ROBIN (http://bioinformatics.mpimp- golm.mpg.de/proiects/own/robin) to generate log fold change of differential gene expression.
  • Fold changes of significantly differentially expressed genes (P ⁇ 0.01) were analyzed with the pathway analysis program MapMan (18; http s : // gabi . rzpd . de/ pr i ects/MapMan/) to map large datasets into diagrams and processes.
  • MapMan (18; http s : // gabi . rzpd . de/ pr i ects/MapMan/) to map large datasets into diagrams and processes.
  • a color code is used to symbolize the fold change of differential gene expression, where blue indicates higher expression, red indicates lower expression and white indicating no change in abi3-6 mutant embryos ( Figure 8).
  • Electrophoretic mobility shift assays were performed as described previously (31, 32). The sequences of all the oligonucleotides are shown in Figure 2D. Both strands of the oligonucleotides were synthesized and annealed. DNA probes were generated by filling in 5' overhangs with the Klenow fragment of DNA polymerase I (Promega) in the presence of [a"32P] dATP and purified using MicroSpin columns (GE Healthcare). Double- stranded DNA with nonradioactive nucleotides were used as competitor DNA.
  • ABA sensitivity assays ABA was dissolved in ethanol and added to the media after sterilization. Mature seeds from Col-0, abi 3-6 and abi3-6/SGR overexpressors were harvested and tested for ABA sensitivity (germination scored as radicle emergence) without stratification. Seeds were tested for germination on half strength Murashige and Skoog (MS) media (without sucrose supplement), in the presence of 10 ⁇ or 25 ⁇ ABA at room temperature. The double sgrl-l/sgr2-2 mutant seeds were analyzed for ABA sensitivity along with the respective single mutants and Col-0 on half strength MS media (without sucrose supplement) with 2 ⁇ and 10 ⁇ ABA. Values are means ⁇ SEM of three biological replicates.
  • Seed protein analysis Seed protein was extracted by grinding mature seeds in an ice-cold mortar with 20 ⁇ mg "1 seed of extraction buffer (100 mM Tris-HCI, pH 8.0, 0.5% SDS, 10% glycerol and 2% ⁇ -mercaptoethanol). Extracts were boiled for 3 min and centrifuged. Equal amount of proteins were resolved by SDS-PAGE using a 10% gel. Proteins were visualized by Coomassie blue staining.
  • extraction buffer 100 mM Tris-HCI, pH 8.0, 0.5% SDS, 10% glycerol and 2% ⁇ -mercaptoethanol
  • Plants from Arabidopsis plants (Col-0 and 35S::ABI3labi3-6) were tagged on the day of flower opening to indicate the day of fertilization/flowering. At various days after flowering (11, 12, 13 DAF), these plants were subjected to freezing (-5°C to -10°C) for 2 hours for 1, 2 or 3 days and returned to normal growth conditions. The plants were also subjected to a day of acclimatization at 4 °C before and after the treatment. Following treatment, plants were allowed to recover for one or two days before seeds were collected for either RNA extraction or allowed to mature and observed for defects in de-greening.
  • Canola plants (WT and RD29A::ABI3) were treated at -3 °C for 3 hours for 2 consecutive days. The plants were also subjected to a day of acclimatization at 4 °C before and after the treatment. Plants were observed and photographed.
  • Fall Frost Tolerance - Flowers from canola plants (WT and RD29A::ABI3) were tagged on the day of flower opening to indicate the day of fertilization/flowering. At various days after flowering (21-28 DAF), these plants were subjected to freezing (-6°C) for 4 hours and returned to normal growth conditions. The plants were also subjected to a day of acclimatization at 4 °C before and after the treatment. Following maturation, the seeds were harvested and observed for presence of green seeds. Seeds were cut in half to show the seed interior after the outer coat was taken off.
  • results abi3-6 is an embryo stay-green mutant: Although multiple ABI3 alleles have been identified with various degrees of ABA insensitivity, not all of these alleles display the green seed phenotype exhibited by the severe alleles of ABI3. To precisely examine the various stages of de-greening during embryo maturation phase, we tagged flowers from Col-0, abiS-8 (weak abiS allele) and abi3-6 right after fertilization, followed by harvesting and comparison of the embryos at various stages post-fertilization indicated by days after flowering/fertilization (DAF).
  • DAF flowering/fertilization
  • ABI3 is highly expressed in the embryo throughout the maturation phase (17; Figure 7C).
  • microarray analyses to identify the transcriptome profile of embryos in their late maturation phase (13 DAF) when embryos begin to enter the de-greening phase (13 DAF to 16 DAF) and when ABI3 expression is maximal (Figure 7C). Microarray was performed with RNA extracted from embryos harvested from siliques at 13 DAF.
  • At4g34520 FAE1 FATTY ACID ELONGATION1
  • At1g32560 Late embryogenesis abundant group 1 / LEA group 1 -3,25
  • At4g21020 Late embryogenesis abundant domain-containing protein / LEA -1.31
  • At2g40100 LHCB4.3 (LIGHT HARVESTING COMPLEX PSII) 2.31
  • At1g45474 LHCA5 (Photosystem I light harvesting complex gene 5) 1 15
  • At3g50820 PSB02 PHOTOSYSTEM II SUBUNIT 0-2; oxygen evolving 1 .86
  • At2g46820 TMP14 Encodes the P subunit of Photosystem I 2.34
  • At4g18480 CHLI 1 (CHLORINA 42) Encodes the CHLI subunit of magnesium chelatase 2 69
  • At3g59400 GUN4 (Genomes uncoupled 4) enhances the activity of Mg-chelatase 1 88
  • At1g44446 CH1 (CHLORINA 1 ) chlorophyll a oxygenase 1 .62
  • At4g02380 SAG 21 (SENESCENCE-ASSOCIATED GENE 21 ) Encodes AtLEA5 6 89
  • At1g21460 Nodulin MtN3 family protein similar to senescence -associated protein-like 2 05
  • At2g44670 Senescence- associated protein-related 1 58
  • At1g74940 Senescence- associated protein-related 1 .35
  • At5g47060 Senescence- associated protein-related 1 .23
  • At4g22920 Similar to tne tomato senescence-inducibie chloroplast stay-green protein 1 -1 .54 SGR1 and SGR2 are upregulated in abi3-6 during embryo maturation: Defects in SGR1 lead to stay-green leaf phenotypes in Arabidopsis and rice, and a stay-green cotyledon phenotype in peas (10). Currently, there is no evidence to suggest that SGR1 is also responsible for embryo de-greening in Arabidopsis and other related species. In public microarray databases, KtSGRl (the only SGR family member represented in the microarray database) expression in maturing seeds mirrored ABI3 expression and was up-regulated following increase in ABI3 expression (Figure 7C).
  • B3 DNA binding domain of ABI3 interacts with the RY cis-motif of SGRl and SGR2 promoter sequences: To determine if the down-regulation of KxSGRl/2 in the abi3-6 embryo is a direct consequence of lack of ABI3-mediated transcriptional activation of SGR1/2, we analyzed the promoter sequences of both SGRl and SGR2 genes. Both promoters possessed the canonical B3 domain binding RY motif CATGCA with variable flanking nucleotides. Electrophoretic mobility shift assays (EMSA) were performed using purified recombinant ABI3 B3 domain with labeled RY sequence motif (27nt) of SGRl and SGR2.
  • EMSA Electrophoretic mobility shift assays
  • SGRl and SGR2 are necessary for seed de-greening in Arabidopsis: Rescue of abi3-6 degreening defect through SGRl/2 overexpression shows that SGRl and 2 are sufficient to drive de-greening in maturing abi3-6 embryos.
  • SGRl and 2 are sufficient to drive de-greening in maturing abi3-6 embryos.
  • RT-PCR analysis of seeds at 16 DAF revealed that in sgrl-1 there was reduced expression of SGRl, while sgr2-2 plants had a complete absence of SGR2 transcripts (Figure 4A).
  • the double mutants (sgrl-l/sgr2-2) mimicked the single mutants in SGRl and SGR2 expression.
  • the present inventors have identified the genetic regulatory network that controls seed de-greening in Arabidopsis.
  • ABB functions in two independent programs; one that regulates seed de-greening through the SGR family and the other that is dedicated to seed maturation and desiccation tolerance (Figure 6).
  • this study demonstrates that the influence of ABB on chlorophyll degradation is seed specific, since abi3-6 plants did not display a stay-green leaf phenotype similar to sgrl-1 when kept under dark conditions ( Figure 12).
  • the transcriptional activation of SGR1/2 by ABB forms an exclusive seed specific de- greening module that is required for successful embryo de-greening.
  • abi3-6/35S::SGR overexpressors other than rescuing the green seed phenotype also reduced the ABA insensitivity of abi3-6 ( Figure 3).
  • lack of SGR1 and SGR2 resulted in marginal ABA insensitivity ( Figure 4).
  • the grs enhancer mutation that results in green seeds in the weak abi3-l background did not alter ABA insensitivity of abi3-l, but these seeds were affected in their longevity (2) unlike the sgrl-l/sgr2-2 mutants.
  • ABI3 results in the increased sensitivity of these lines to endogenous ABA, which in turn leads to priming for freezing and desiccation tolerance within the seed.
  • the increased expression of ABB may directly alter ABB -dependent transcripts required for chlorophyll degradation (SGR1, SGR2) and freezing/desiccation tolerance (RAB18) ( Figures 5B, 13).
  • SGR1, SGR2 chlorophyll degradation
  • RAB18 freezing/desiccation tolerance
  • This ABB -dependent priming allows these seeds to withstand the freezing treatment and continue to de-green to produce mature brown seeds.
  • these two models are not mutually exclusive and both ABA sensitivity and ABB may be required for the seed priming and freezing tolerance.
  • ABB functions as the master regulator of de-greening during embryo maturation, through transcriptional control of SGR1 and SGR2 ( Figure 6). This ABB-mediated de-greening process is independent of acquisition of desiccation tolerance and is partially coupled to ABA sensitivity.
  • MAPMAN a user-driven tool to display genomics data sets onto diagrams of metabolic pathways and other biological processes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un procédé permettant d'induire chez une plante la capacité de produire des graines qui éliminent la chlorophylle dans des conditions de stress. Le procédé consiste à moduler l'activité ou l'expression dans des graines de la plante, le facteur de transcription ABA-insensitive 3 (ABI3) et/ou les protéines de dégradation de la chlorophylle Staygreen 1 (SGR1) ou Staygreen 2 (SGR2), ou un polypeptide possédant une activité ABI3, SGR1 ou SGR2. L'invention concerne aussi des constructions d'acides nucléiques isolées, et leur inclusion stable dans des plantes transgéniques. Les plantes transgéniques ont des caractéristiques phénotypiques souhaitables présentées en comparaison avec des plantes témoins, notamment la capacité de produire des graines qui éliminent la chlorophylle dans des conditions de stress, telles que des températures froides ou des stress environnementaux.
PCT/CA2014/050793 2013-08-19 2014-08-19 Plantes produisant des graines qui éliminent la chlorophylle pendant la maturation dans des conditions de stress WO2015024119A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2921071A CA2921071A1 (fr) 2013-08-19 2014-08-19 Plantes produisant des graines qui eliminent la chlorophylle pendant la maturation dans des conditions de stress

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361867418P 2013-08-19 2013-08-19
US61/867,418 2013-08-19

Publications (1)

Publication Number Publication Date
WO2015024119A1 true WO2015024119A1 (fr) 2015-02-26

Family

ID=52482882

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2014/050793 WO2015024119A1 (fr) 2013-08-19 2014-08-19 Plantes produisant des graines qui éliminent la chlorophylle pendant la maturation dans des conditions de stress

Country Status (2)

Country Link
CA (1) CA2921071A1 (fr)
WO (1) WO2015024119A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108794612A (zh) * 2018-06-28 2018-11-13 中国农业科学院棉花研究所 植物种子脂肪酸相关蛋白GhbZIP67及其编码基因和应用
WO2022207114A1 (fr) * 2021-04-01 2022-10-06 Enza Zaden Beheer B.V. Plante cucurbitacée dite « stay green » (toujours verte)
CN117965566A (zh) * 2024-04-02 2024-05-03 中国农业科学院生物技术研究所 一种与烟草叶片衰老相关的基因家族及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079168A2 (fr) * 2004-02-23 2005-09-01 Seoul National University Industry Foundation Nouveau gene stay-green et procede de preparation de vegetaux transgeniques stray-green
US7446241B2 (en) * 2002-07-30 2008-11-04 Texas Tech University Transcription factors, DNA and methods for introduction of value-added seed traits and stress tolerance
US7847156B2 (en) * 2003-10-20 2010-12-07 Cropdesign N.V. Plants having improved growth characteristics and methods for making the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7446241B2 (en) * 2002-07-30 2008-11-04 Texas Tech University Transcription factors, DNA and methods for introduction of value-added seed traits and stress tolerance
US7847156B2 (en) * 2003-10-20 2010-12-07 Cropdesign N.V. Plants having improved growth characteristics and methods for making the same
WO2005079168A2 (fr) * 2004-02-23 2005-09-01 Seoul National University Industry Foundation Nouveau gene stay-green et procede de preparation de vegetaux transgeniques stray-green

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108794612A (zh) * 2018-06-28 2018-11-13 中国农业科学院棉花研究所 植物种子脂肪酸相关蛋白GhbZIP67及其编码基因和应用
CN108794612B (zh) * 2018-06-28 2021-08-10 中国农业科学院棉花研究所 植物种子脂肪酸相关蛋白GhbZIP67及其编码基因和应用
WO2022207114A1 (fr) * 2021-04-01 2022-10-06 Enza Zaden Beheer B.V. Plante cucurbitacée dite « stay green » (toujours verte)
CN117965566A (zh) * 2024-04-02 2024-05-03 中国农业科学院生物技术研究所 一种与烟草叶片衰老相关的基因家族及其应用

Also Published As

Publication number Publication date
CA2921071A1 (fr) 2015-02-26

Similar Documents

Publication Publication Date Title
CA2957986C (fr) Tolerance aux contraintes biotiques et abiotiques chez les plantes
EP1485490B1 (fr) Polynucleotides et polypeptides utilises dans des plantes en vue d'ameliorer leurs caracteristiques
US7888558B2 (en) Conferring biotic and abiotic stress tolerance in plants
EP1230345B1 (fr) Genes resistant au stress environnemental
US7956242B2 (en) Plant quality traits
EP1682668B1 (fr) Regulateurs transcriptionnels de plantes
EP2298918B1 (fr) Regulation de la biomasse et de la tolerance au stress de plantes
US20070226839A1 (en) Biotic and abiotic stress tolerance in plants
US20050086718A1 (en) Plant transcriptional regulators of abiotic stress
US8283519B2 (en) Plant transcriptional regulators of abiotic stress
US20090205063A1 (en) Plant polynucleotides for improved yield and quality
US20110138499A1 (en) Plant quality traits
US20140380520A1 (en) Manipulating plant sensitivity to light
WO2015024119A1 (fr) Plantes produisant des graines qui éliminent la chlorophylle pendant la maturation dans des conditions de stress
US20130031669A1 (en) Plant transcriptional regulators of abiotic stress ii
EP1566444A2 (fr) Genes propres au rendement
EP1673462A2 (fr) Regulateurs transcriptionnels vegetaux du stress abiotique
US20140201861A1 (en) Polynucleotides and polypeptides that confer increased yield, size or biomass

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2921071

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14837857

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 14837857

Country of ref document: EP

Kind code of ref document: A1